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Abstract
Early life environment can impact disease risk later in life, a concept known as the developmental origins
of health and disease (DOHaD). Furthermore, the effects may persist across several generations of
offspring. The underlying molecular dysregulation driving these phenotypes, however, remain unknown.
Using the ubiquitous endocrine disrupting chemical (EDC) bisphenol A (BPA) as a model estrogen, we
investigated the physiological and molecular consequences of chronic, low-dose developmental BPA
exposure across the lifespan, using a mouse model system. To assess the transmission of phenotypes
across generations, we examined physiological endpoints across two generations of offspring in each
study. In Chapter 2, we report a depressive-like behavioral phenotype in BPA-exposed offspring that is
exclusive to males in the first filial (F1) generation. Molecular assessments in the adult hippocampus
using RNA-sequencing and HPLC revealed sex-specific reductions in the neurotransmitter serotonin, a
critical regulator of mood. Additionally, levels of dehydroepiandrosterone, a sex steroid intermediate, were
reduced in serum and hippocampal tissue, which could also explain the observed behavioral changes. In
Chapter 3, we report impaired metabolic health in F1 and F2 generation adult male offspring that may be
partially due to increased expression of the imprinted insulin-like growth factor 2 (Igf2) gene. Gestational
glucose intolerance could also be contributing to the phenotype in F1, but not F2, generation offspring.
Finally, in Chapter 4, we describe our early findings on BPA exposure-associated skeletal changes.
Developmental BPA exposure is associated with thinner and weaker bones in F1 male mice, while F2
males exhibit an adaptive response. Whether the sex-specific phenotypes reported in these studies
manifest at a younger age, prior to puberty, remains an ongoing area of study. Taken together, work in this
dissertation demonstrates sex-, dose- and generation-specific effects associated with early life BPA
exposure. Understanding the exposure-associated effects and mechanism(s) of BPA and other EDC
actions is critical for assessing chemical safety. Identifying dysregulated pathways may also allow for
targeted intervention strategies to reduce or prevent EDC exposure-associated effects. Ultimately,
findings from these studies and others utilizing models representative of human exposure may aid in
future regulatory decision-making.
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ABSTRACT
PHYSIOLOGICAL AND MOLECULAR CHANGES ACROSS THE LIFESPAN FOLLOWING
DEVELOPMENTAL CHEMICAL EXPOSURE
Frances Xin
Dr. Marisa S. Bartolomei

Early life environment can impact disease risk later in life, a concept known as the
developmental origins of health and disease (DOHaD). Furthermore, the effects may persist
across several generations of offspring. The underlying molecular dysregulation driving these
phenotypes, however, remain unknown. Using the ubiquitous endocrine disrupting chemical
(EDC) bisphenol A (BPA) as a model estrogen, we investigated the physiological and molecular
consequences of chronic, low-dose developmental BPA exposure across the lifespan, using a
mouse model system. To assess the transmission of phenotypes across generations, we
examined physiological endpoints across two generations of offspring in each study. In Chapter
2, we report a depressive-like behavioral phenotype in BPA-exposed offspring that is exclusive to
males in the first filial (F1) generation. Molecular assessments in the adult hippocampus using
RNA-sequencing and HPLC revealed sex-specific reductions in the neurotransmitter serotonin, a
critical regulator of mood. Additionally, levels of dehydroepiandrosterone, a sex steroid
intermediate, were reduced in serum and hippocampal tissue, which could also explain the
observed behavioral changes. In Chapter 3, we report impaired metabolic health in F1 and F2
generation adult male offspring that may be partially due to increased expression of the imprinted
insulin-like growth factor 2 (Igf2) gene. Gestational glucose intolerance could also be contributing
to the phenotype in F1, but not F2, generation offspring. Finally, in Chapter 4, we describe our
early findings on BPA exposure-associated skeletal changes. Developmental BPA exposure is
associated with thinner and weaker bones in F1 male mice, while F2 males exhibit an adaptive
response. Whether the sex-specific phenotypes reported in these studies manifest at a younger
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age, prior to puberty, remains an ongoing area of study. Taken together, work in this dissertation
demonstrates sex-, dose- and generation-specific effects associated with early life BPA exposure.
Understanding the exposure-associated effects and mechanism(s) of BPA and other EDC actions
is critical for assessing chemical safety. Identifying dysregulated pathways may also allow for
targeted intervention strategies to reduce or prevent EDC exposure-associated effects.
Ultimately, findings from these studies and others utilizing models representative of human
exposure may aid in future regulatory decision-making.
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INTRODUCTION
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CHAPTER 1. INTRODUCTION

Some quotes and/or figures in this chapter were taken directly from Xin et al. (2015) Seminars in
Cell and Developmental Biology and Xin et al. (In Press) Environmental Epigenetics.

1.1. Developmental Origins of Health and Disease (DOHaD) Hypothesis
The developmental origins of health and disease (DOHaD) hypothesis posits growth
conditions in utero are capable of affecting health trajectories throughout postnatal life (Barker et
al. 1989). The hypothesis was based on initial observations by David Barker and colleagues who
reported a correlation between low birth weight and increased risk of cardiovascular and
metabolic diseases in adulthood. Since its inception, the DOHaD hypothesis has expanded to
include a variety of environmental perturbations and disease states (Xin et al. 2015). While
human and rodent studies have demonstrated links between adverse early life events and
increased disease risk in adulthood, the underlying mechanisms driving these changes remain
unclear.
The fetus and neonate represent particularly vulnerable populations to environmental
perturbations, such as chemical exposures. One reason for this is that the enzymes involved in
xenobiotic biotransformation and the processes required to eliminate exogenous chemicals are
incompletely developed in the fetus and neonate relative to adults (Aguilar et al. 2008; Choudhary
et al. 2003a; de Wildt et al. 1999). Exposure to toxic compounds could, therefore, accumulate to
levels sufficient to elicit adverse effects on target organs among these populations. Another key
event during embryogenesis, with potential long-term ramifications if disrupted, is epigenetic
reprogramming (Saitou et al. 2012). Epigenetic reprogramming allows for the establishment of a
clean slate upon which cell type-specific patterns of gene expression can be established (Saitou
et al. 2012). Disruptions in the erasure, establishment, and/or maintenance of these intricate and
highly coordinated gene expression patterns could alter susceptibility to later life events and
affect disease risk. The role of epigenetic reprogramming in DOHaD will be discussed in greater
detail in section 1.1.2.

2

1.1.1. Multigenerational and transgenerational inheritance
The potential transmission of phenotypes across generations, known as multi- and
transgenerational inheritance, has become a topic of interest within the DOHaD field, particularly
in mammalian systems. The manifestation of phenotypes across generations with direct exposure
to the initial stimulus is known as a multigenerational effect. In the case of a gestating mother
(designated the filial (F) 0 generation), an exposure could affect the mother, the developing fetus
(F1 generation), and the germ cells of the fetus (F2 generation) (Figure 1.1). For a phenotype to
be observed in the F2 generation, exposures would have to affect the F1 fetal germ cells directly,
or indirectly through altered supporting cell function. Although the F0-F2 generations are all
directly exposed to the original stimulus, the exposure occurs during distinct life stages, each
possessing a unique set of molecular pathways that could be susceptible to the initial insult. As a
result, the outcomes associated with the exposure may vary across generations. If effects persist
to a generation with no direct exposure, such as the F3 generation in this example, this would be
considered a transgenerational effect. When an exposure occurs through the F0 father or F0
mother prior to gestation, multigenerational and transgenerational effects are observed in the F1
and F2 generation, respectively (Figure 1.1).
Support for multi- and transgenerational effects in humans has surfaced. Two commonly
referenced human populations reporting multi- and transgenerational nutrition-associated effects
include the Överkalix Parish of northern Sweden and offspring of the Dutch famine, or Dutch
Hunger Winter (Pembrey et al. 2014). Food supply during a critical prepubertal window in midchildhood was associated with altered longevity and specific causes of mortality (e.g.
cardiovascular or diabetic mortality) in children and grandchildren of the Överkalix population
(Pembrey et al. 2014). When females – who had experienced the Dutch famine in utero –
became mothers, their own children were at greater risk of neonatal adiposity and other
detrimental health effects (Painter et al. 2008). Conversely, offspring of males exposed to the
famine in utero were not affected. A multigenerational study in the Avon Longitudinal Study of
Parents and Children (ALSPAC) cohort reported increased birth weight in sons of non-smoking
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ALSPAC mothers if the mothers had been exposed to smoke in utero compared to sons from
mothers and grandmothers with no history of indirect or direct exposure to smoking (Miller et al.
2014). Exposure to the synthetic estrogenic compound diethylstilbestrol (DES) in utero was
associated with an increased incidence of a rare vaginal cancer in offspring (Herbst et al. 1971),
and increased frequencies of reproductive abnormalities have also been reported in female and
male grandchildren of DES-treated women (Hilakivi-Clarke 2014). These human epidemiological
studies demonstrate susceptibility of both maternal and paternal germlines to environmental
perturbations that can be transmitted to future generations of offspring.

1.1.2. Epigenetics: A mechanistic link for gene-environment interactions
How phenotypes can be transmitted from one generation to the next, independent of
changes to the DNA sequence itself, has been an ongoing topic of investigation. Epigenetic
regulation has surfaced as an attractive mediator for gene-environment interaction effects given
its plasticity and sensitivity to environmental cues (Heard and Martienssen 2014). Epigenetic
modifications are also stable and heritable through cell division, allowing for the propagation of
proper, or improper, marks throughout development.
One of the most extensively studied epigenetic regulatory marks subject to environmental
signals is DNA methylation. DNA methylation is critical for proper development, with central roles
in regulating cell fate, genome stability, X chromosome inactivation, and genomic imprinting
(Schübeler 2015). DNA methylation in gene promoters is typically associated with transcriptional
repression, while DNA methylation in distal regulatory elements is thought to be important for the
control of tissue-specific gene expression patterns during development (Schübeler 2015). DNA
methylation is catalyzed by the DNA methyltransferase (DNMT) family of enzymes through the
addition of a methyl group to the cytosine base, typically within the context of CpG dinucleotides.
The active removal of DNA methylation marks is controlled, in part, by the ten-eleven translocase
(TET) family of enzymes (Schübeler 2015; Tahiliani et al. 2009). The improper function of any of
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these epigenetic enzymes could alter epigenetic profiles, transcriptional programs, and
subsequent sensitivity to later life challenges and/or disease risk.
During early mammalian development, the genome undergoes two extensive, DNA
methylation-dependent, waves of epigenetic reprogramming (Saitou et al. 2012). The first wave
occurs during the post-zygotic/pre-implantation stage of development, and the second wave
occurs exclusively in the fetal germline (Saitou et al. 2012). With each round of reprogramming,
epigenetic landscapes are erased and reset to confer the appropriate transcriptional profile for
each cell type (Saitou et al. 2012). While most epigenetic marks in the genome are erased, some
marks are retained, providing a possible mechanism for multi- and transgenerational inheritance.
These mechanisms will be discussed in greater detail in the following sections.

Epigenetic reprogramming in post-zygotic/pre-implantation development
Shortly after fertilization, the majority of epigenetic marks across the genome are erased
to establish pluripotency in the F1 zygote (Saitou et al. 2012). New epigenomic profiles are then
created to promote proper transcriptional programs for given somatic cell types (Saitou et al.
2012). Two regions of the genome, however, escape this initial wave of reprogramming and may
facilitate the transmission of phenotypes across generations: differentially methylated regions
(DMRs) that regulate imprinted and some non-imprinted genes, as well as repetitive elements
such as intracisternal A particle (IAP) retrotransposons (Saitou et al. 2012).
Imprinted genes have garnered attention as vulnerable loci to environmental
perturbations in the developing zygote. In contrast to most genes in the genome that are
expressed biallelically, imprinted genes are expressed in a monoallelic manner, from either the
maternal or paternal allele. This monoallelic expression is controlled by differential DNA
methylation at regulatory regions known as imprinting control regions (ICRs) (Abramowitz and
Bartolomei 2012). Given their critical role in growth and development, imprinted gene
dysregulation is often characterized by over- or undergrowth, as seen in individuals with
Beckwith-Wiedemann or Silver-Russell syndromes, respectively (Bartolomei and Ferguson-Smith
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2011). Many human imprinting disorders are also associated with cognitive impairments,
suggesting a critical role for imprinted genes in neurodevelopment (Bartolomei and FergusonSmith 2011). Imprinted genes represent loci of interest in environmental exposure studies given
their sensitivity to disruption – improper silencing of the only active allele results in complete loss
of gene function. Additionally, imprinted genes may be strong candidates to explain
multigenerational phenotypes given their resistance to reprogramming during the postzygotic/preimplantation wave (Saitou et al. 2012): if DNA methylation at ICRs is disrupted, the
epigenetic profile at imprinted loci only have one chance of being corrected during
reprogramming instead of two. As the regulators of DNA methylation and the mechanisms of
imprinting are conserved in mammals, studies in rodent models can be extrapolated to
understand risks of environmental exposures on human health.

Epigenetic reprogramming in primordial germ cell (PGC) development
The cells specified to become the germ cells of the developing F1 embryo, the F2
generation, undergo a second and more complete wave of epigenetic reprogramming (Hackett et
al. 2013; Saitou et al. 2012; Seisenberger et al. 2012). Unlike the first wave, epigenetic marks at
ICRs are erased and reset this time, allowing for the proper establishment of epigenetic marks in
fetal germ cells according to the sex of the developing embryo. However, a subset of
retrotransposons such as IAPs continue to be resistant to reprogramming (Hackett et al. 2013;
Seisenberger et al. 2012). The retention of DNA methylation at these repetitive elements likely
helps to maintain genomic stability and reduce the risk of insertional mutations (Saitou et al.
2012). Furthermore, genes adjacent to these repetitive elements are also subject to
reprogramming resistance. Improper silencing of repetitive elements and the adjacent genes has
been suggested to be a mode of transgenerational epigenetic inheritance (Daxinger and
Whitelaw 2012).
Two studies have applied genome-wide DNA methylation techniques to comprehensively
assess the epigenomic landscape during reprogramming (Hackett et al. 2013; Seisenberger et al.
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2012). Both Seisenberger et al. and Hackett et al. identified loci that escape reprogramming in
PGCs, the majority of which were associated with repetitive elements. Additionally, ~200 singlecopy loci were found to escape reprogramming in E13.5 female primordial germ cells (PGCs),
and ~90 single-copy loci in males (Hackett et al. 2013; Seisenberger et al. 2012). No gene
ontology or pathway analyses were performed on the escape genes to determine enrichment for
biological processes. One escape gene of interest, however, was Exoc4, which has been
associated with type 2 diabetes and insulin-stimulated glucose transport (Seisenberger et al.
2012). These reprogramming-resistant loci, therefore, represent prime candidates for
transgenerational inheritance in mammals.

Final considerations and conclusion
If the mechanism(s) susceptible to environmental disruptions are different within the F1
and F2 generations, it is possible that physiological responses to the initial stimulus could also
vary. Not only could changes be generation-specific, but responses to stimuli could be protective.
In the face of an adverse stimulus such as inadequate nutrition during gestation, fetal
programming may shape a predictive adaptive response (i.e. offspring expect to be faced with
similar environments as those experienced in the womb) (Pembrey et al. 2014). For example, in a
model of chemically-induced liver injury, F2 generation offspring from F0 and F1 paternally
affected sires developed increased resistance to liver injury compared to F2 generation offspring
from vehicle-treated F0 and F1 sires (Zeybel et al. 2012). Interestingly, the increased expression
of a critical gene at least partially responsible for the adaptive phenotype in ancestrally exposed
F2 offspring, peroxisome proliferator-activated receptor gamma (Pparg), was associated with
reduced DNA methylation and increased acetylated histone H3 at its promoter (Zeybel et al.
2012). This study highlights a role for epigenetics in enhancing the fitness of future generations
when faced with equivalent environmental pressures.
In sum, early development represents a very dynamic period of growth and establishment
of proper cell and organ system fates. Perturbed epigenetic reprogramming, particularly at
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imprinted genes, repetitive element-adjacent genes, and other reprogramming-resistant singlecopy loci, could influence disease risk across multiple generations of offspring.

1.2. Endocrine Disrupting Chemicals: Bisphenol A
Public health concerns have risen as a consequence of the mounting evidence for
disorders in humans, wildlife, and laboratory animals linked to developmental endocrine
disrupting chemical (EDC) exposure (Bergman et al. 2013). EDCs are natural or synthetic
compounds capable of interfering with the biosynthesis, storage, release, transport, and/or
receptor binding of endogenous hormones, ultimately interfering with the function and timing of
hormone action (Yoon et al. 2014). Interestingly, a commonly observed phenomenon in EDC
exposure studies is the occurrence of sex-specific effects (Xin et al. 2015). About 800 commercial
chemicals are suspected to interfere with the endocrine system, although only a small fraction of
these has been tested for potential adverse effects (Bergman et al. 2013).
One EDC that has been in the public eye is bisphenol A (BPA), a ubiquitous chemical
commonly used in polycarbonate plastics and epoxy resins (Aguilar et al. 2008; Bergman et al.
2013). While BPA was first synthesized in 1891, it was not evaluated for its estrogenic properties
until the 1930s, when it was found to be a weak estrogen compared to endogenous estradiol
(Dodds and Lawson 1938, 1936; Vandenberg et al. 2012). Since the 1950s, BPA has been used
in polycarbonate plastics to promote rigidity, epoxy resins to form a protective layer on the interior
of metal food cans, and in thermal paper products as a color developer to allow for inkless
printing (Björnsdotter et al. 2017; Michałowicz 2014). Given its high production volume and
widespread use in everyday, it is not surprising that virtually all sampled individuals in the United
States population have detectable urinary levels of BPA (Calafat et al. 2005). BPA has been an
extensively studied chemical, and developmental exposure has been associated with a myriad of
adverse health outcomes in rodents and humans, including reproductive, metabolic, and cognitive
defects (Xin et al. 2015). However, its precise mechanism(s) of action on these, and lesserstudied, organ systems are still unclear.
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1.2.1. BPA Regulation
Based on long-term adult exposure studies in a rat model, the United States
Environmental Protection Agency (EPA) established a BPA reference dose (RfD) of 50 μg/kg/day
for humans in 1982 (Integrated Risk Information System (IRIS) 1988; Michałowicz 2014). The
RfD is considered an estimate of daily exposure that is not likely to elicit appreciable risk or
deleterious effects throughout the lifetime (Integrated Risk Information System (IRIS) 1988). The
European Food and Safety Authority (EFSA) also established a BPA tolerable daily intake (TDI)
of 50 μg/kg/day, while the Food Directorate of Health Canada instituted a TDI of 25 μg
BPA/kg/day (Michałowicz 2014).
As the number of reports demonstrating a link between BPA exposure and disease risk
grew, regulatory agencies responded to growing concerns of BPA safety. In 2008, Canada
became the first country to ban BPA from baby bottles in 2008, with the European Commission
and the United State Food and Drug Administration following in 2011 and 2012, respectively
(Michałowicz 2014). The EFSA issued a ‘temporary TDI’ of 4 μg/kg/day while the risks associated
with BPA exposure are being re-evaluated (MacKay and Abizaid 2017; Michałowicz 2014).

1.2.2. BPA Toxicokinetics
Absorption and distribution
Exposure to BPA can occur through multiple routes, with ingestion being a primary mode
of exposure (Michałowicz 2014; vom Saal and Welshons 2014). Following entry into the body, the
distribution of BPA across tissues is widespread. Detection of BPA in human and rodent adipose
suggests that BPA is lipophilic and may accumulate in solid tissues (Doerge et al. 2011;
Fernandez et al. 2007; Geens et al. 2012). BPA is also capable of crossing the placenta and
blood-brain barrier (Negri-Cesi 2015; Sajiki et al. 1999). In humans, other tissues containing
detectable levels of BPA include the fetal and adult liver (Geens et al. 2012; Nahar et al. 2015) as
well as fetal kidney (Nahar et al. 2015).
Metabolism and excretion
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In humans, orally administered BPA undergoes first-pass metabolism in the liver, with
BPA-glucuronide and BPA-sulfate representing the major and minor urinary metabolites,
respectively (Aguilar et al. 2008). The half-life of BPA has been reported to be less than six hours,
with most administered BPA leaving the body within 48 hours (Aguilar et al. 2008; MacKay and
Abizaid 2017). In rats, BPA is also predominantly glucuronidated, while sulfation represents a
minor pathway (Aguilar et al. 2008). Unlike humans, however, BPA undergoes enterohepatic
recirculation in rats, resulting in higher plasma levels of unconjugated BPA and slower elimination
with terminal elimination half-lives between 20 and 80 hours (Aguilar et al. 2008).

1.2.3. BPA toxicodynamics: Possible mechanisms of action
Because developmental exposure to BPA is associated with a myriad of phenotypes, it is
unlikely that BPA acts through a single mechanism. A hallmark of EDCs is their ability to elicit
non-monotonic dose responses, suggesting low dose effects cannot be extrapolated from effects
observed at higher doses (Vandenberg 2014). Therefore, varied responses may be due to distinct
mechanisms of action at each dose. Although the mechanisms of EDC action are complex, they
are crucial to our understanding of how adverse phenotypes manifest and to the development of
intervention and/or prevention strategies to reduce exposure-associated disease risk. In this
section, proposed mechanisms of BPA action will be discussed, with a focus on its best-studied
estrogenic role and evidence for BPA-induced epigenetic dysregulation.

Classical and non-classical estrogen receptor (ER)-mediated pathways
Although BPA can bind to the classical nuclear estrogen receptors α (ERα) and β (ERβ),
its affinity for these receptors is 1,000 – 10,000 times lower than estradiol (Michałowicz 2014;
Vandenberg et al. 2012). Nevertheless, BPA is still capable of eliciting estrogenic responses in
multiple tissue types comparable in magnitude to endogenous estrogen (Nadal et al. 2009;
Watson et al. 2007). Further investigations have demonstrated that very low levels of BPA, within
the pico- and nanomolar ranges, are sufficient to induce effects via nonclassical ERs located on
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the cell membrane (Wetherill et al. 2007). These membrane-initiated pathways elicit rapid cellular
responses through the activation of signaling cascades (MacKay and Abizaid 2017).
Two non-classical ERs commonly implicated in BPA exposure-associated effects are the
G protein-coupled estrogen receptor (GPER, also known as GPR30) and the estrogen-related
receptor (ERR) family. GPER is a membrane-bound receptor with affinity for estradiol and BPA
(MacKay and Abizaid 2017; Natale et al. 2016). The binding affinity of BPA to GPER is 8-50 times
greater than its affinity for the classical ERα receptor (Thomas and Dong 2006). As a GPER
agonist and estrogen mimic, binding of BPA increases adenylyl cyclase activity and activates
downstream pathways similar to estradiol (MacKay and Abizaid 2017; Natale et al. 2016; Thomas
and Dong 2006). The nuclear ERR family, which is comprised of ERRα, ERRβ, and ERRγ, does
not bind endogenous estrogen (MacKay and Abizaid 2017). However, unliganded ERRs can
activate classical estrogen response elements and disrupt ER-mediated signaling (MacKay and
Abizaid 2017). The binding of agonists or antagonists to ERR could further modulate its activity
(Horard and Vanacker 2003). Numerous studies have demonstrated high affinity of BPA for ERRγ
(Okada et al. 2007; Takayanagi et al. 2006; Tohmé et al. 2014). ERRγ has been reported to
function in multiple organ systems, with roles in nervous system development (HermansBorgmeyer et al. 2000), metabolism (Misra et al. 2016; Shirakawa and Kulkarni 2016), and
skeletal growth (Cardelli and Aubin 2014). Therefore, BPA may disrupt endogenous estrogen
activity through the improper activation of classical and non-classical ER-mediated pathways.

Non-estrogenic mechanisms of BPA action
Several other hormone-mediated pathways have been suggested to mediate BPA
exposure-associated effects. Glucocorticoid receptors (GR) are ubiquitously expressed and
possess a multitude of responses upon stimulation (MacKay and Abizaid 2017). Given the
parallel effects reported in offspring exposed to prenatal stress or BPA (Alonso-Magdalena et al.
2010; Lian et al. 2018; Palanza et al. 2016; Paternain et al. 2013), glucocorticoid-mediated
pathways may be a key mechanistic link in BPA exposure-induced phenotypes. In silico modeling

11

predicts that BPA can bind to GR with similar binding energy as endogenous cortisol and
exogenous dexamethasone, suggesting BPA could be a GR-agonist (Prasanth et al. 2010).
BPA may also disrupt androgen-associated pathways in a receptor-dependent or independent manner. In vitro studies demonstrated anti-androgenic activity of BPA via
competitive binding to the androgen receptor (AR) (Sohoni and Sumpter 1998; Xu et al. 2005).
BPA is capable of inhibiting androgenic activity induced by endogenous dihydrotestosterone
(DHT) with a median inhibitory concentration (IC50) comparable to the potent antiandrogen
flutamide (Xu et al. 2005). Other anti-androgenic, AR-independent activities of BPA include the
disruption of androgen biosynthesis in vitro and in vivo (Fang et al. 2017; Lan et al. 2017).
Androgen deficiency could lead to systemic, and male-specific, effects.
Other commonly cited pathways disrupted by BPA exposure include thyroid hormone
receptors, peroxisome proliferator-activated receptors (PPARs), aryl hydrocarbon receptor (AhR)
(MacKay and Abizaid 2017; Rubin 2011). The extent to which each pathway may be driving the
effects of BPA likely depends on context. Given its plurality of molecular targets, the activities of
BPA extend well beyond its classification as an estrogenic EDC.

Epigenetics
Dolinoy and colleagues were among the first to demonstrate that fetal BPA exposure is
capable of inducing changes in DNA methylation at the agouti (Avy) locus in mice, which
correlated with shifts in offspring coat color (Dolinoy et al. 2007). Later, studies from our lab and
others reported epigenetic changes at developmentally relevant loci following early life exposure
to BPA (Bromer et al. 2010; Chao et al. 2012; Prins et al. 2008; Susiarjo et al. 2013, 2015;
Wolstenholme et al. 2011b). BPA has also been shown to alter DNA methylation at select loci in
cultured oocytes (Chao et al. 2012), suggesting the germ cell epigenome is a target of BPA.
Changes in the germ cell that do not get corrected during subsequent waves of reprogramming
could result in persistent health effects across future generations of offspring. The altered DNA
methylation profiles in some of these studies were associated with altered expression of DNMTs
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(Chao et al. 2012; Wolstenholme et al. 2011b). To our knowledge, no BPA exposure studies have
assessed changes in TET expression.
In addition to locus-specific epigenetic changes associated with BPA exposure,
perturbations in global DNA methylation have been reported in rodents and humans (Nahar et al.
2015; Susiarjo et al. 2013), suggestive of altered epigenome stability. Epigenome instability has
been linked to an increased risk for several adverse health outcomes, including diabetes
(Williams et al. 2008), neurological disorders (Mastroeni et al. 2009), and cancer (Ehrlich 2009).
While the evidence for BPA exposure-associated epigenetic dysregulation continues to increase,
few studies have demonstrated a causal role for altered epigenetic regulation in BPA exposureinduced phenotypes. Incorporating genetically engineered mouse models deficient for epigenetic
regulatory enzymes into exposure-based studies will help to address the necessity of specific
epigenetic factors in mediating the observed phenotypes.

1.2.4. Recent controversy regarding the safety of BPA
The National Toxicology Program (NTP), NIEHS, and FDA developed a collaboration
between government and academic scientists to comprehensively assess the potential effects of
BPA exposure following standardized, government-compliant research guidelines (Heindel et al.
2015; Schug et al. 2013). The collaboration is known as the Consortium Linking Academic and
Regulatory Insights on BPA Toxicity, or CLARITY-BPA. In late February 2018, the government
side of the consortium released a draft report, that has not yet undergone peer-review, concluding
early life exposure to BPA elicits “minimal effects” (National Toxicology Program 2018). The
limited endpoints evaluated in the draft report included whole organism growth, tissue weight,
tissue morphology, and tumor development. Of note, certain doses of BPA were linked to a
higher rate of mammary gland tumors (National Toxicology Program 2018). Unfortunately, the
findings from this initial report have drawn significant attention in popular press and has called
into question the risks associated with BPA exposure (Hamilton 2018; Sheridan 2018; Yeager
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2018). The government draft report will undergo a public peer-review session on April 26, 2018
(Sheridan 2018).
Academic members of the consortium reported disappointment in the hasty release of the
government research findings, stating that the conclusions drawn from these studies were
premature given the incomplete set of endpoints to be evaluated by the consortium (Sheridan
2018; Yeager 2018). The brain is a critically sensitive endocrine tissue that was not assessed in
the draft report. As of March 2018, at least nine peer-reviewed publications from academic
institutions belonging to the CLARITY consortium have been released. Of those nine
manuscripts, five assessed neurobehavioral endpoints, and four of the five studies saw significant
changes in brain morphology, gene expression, or animal behavior associated with BPA
exposure (Arambula et al. 2016, 2017b, 2017a; Johnson et al. 2016). Together, the government
and academic research findings thus far suggest organ-specific vulnerabilities to BPA that
requires further study. A final report that includes findings from the academic scientists in the
consortium is set to be released in 2019 and will aid in policy decisions on BPA.

Limitations in CLARITY-BPA study design
Additional concerns regarding the conclusions reported by the government scientists
relate to limitations in experimental design. While a major strength of the consortium is its
standardized operating procedure, the chosen route of BPA administration and window of
exposure have their shortcomings.
To briefly introduce the system, the multi-arm exposure model exposes Sprague-Dawley
rats to BPA beginning at day 6 of gestation and continues throughout the lifespan of the offspring
(up to two years) or stops at the end of lactation. BPA is administered via gavage to the gestating
dam and then directly to pups the day after parturition. The five doses of BPA range from 2.5 to
25,000 µg/kg bw/d.
Delivery of compounds by intra-gastric gavage has been the common route of
administration in toxicology studies given the ability to precisely control timing and dose
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(Vandenberg et al. 2014). However, the insertion of a tube down the esophagus of the animal to
allow for direct and acute delivery of the compound to the stomach does not accurately model
human chronic oral exposure to BPA. Furthermore, the stress induced by restraint and gavage
could confound the effects of BPA through the disruption of the hypothalamic-pituitary-adrenal
axis as well as cardiovascular endpoints such as blood pressure and heart rate (Vandenberg et
al. 2014). Elevated stress hormones during pregnancy have been associated with increased risk
of obesity (Paternain et al. 2013) and altered affective behavior (Lian et al. 2018) in offspring.
Therefore, the gavage methodology utilized by the CLARITY consortium could induce stress
responses that complicate the distinction of BPA exposure-associated effects from the effects of
stress. Furthermore, daily activation of stress responses may affect responsivity to later life
events, increasing the probability of false negative or false positive findings (Vandenberg et al.
2014).
Furthermore, the exposure neglects a critical window of susceptibility in early
development. By waiting until E6 to begin the exposure, the post-zygotic/pre-implantation wave of
epigenetic programming is almost entirely spared, allowing for epigenetic landscapes in somatic
cells to be erased and reestablished free of potential interference (Saitou et al. 2012). In support
of early gestation representing an exceptionally vulnerable period in development, we previously
reported tissue-specific imprinting defects in embryos exposed to BPA from E0-E12.5, while
imprinted gene regulation and expression remained intact when the exposure occurred outside of
the reprogramming window, from E5.5-E12.5 (Susiarjo et al. 2013). Similarly, when Kang and
colleagues exposed embryos to BPA (200 µg/kg/d) from E8.5-E12.5, imprinted genes were
minimally disrupted (Kang et al. 2011). While we cannot rule out the possibility that the longer
duration of BPA exposure may have contributed to the fetal imprinting defects, our study supports
the notion that perturbations in early gestation may be sufficient to disrupt gene expression
profiles and associated developmental trajectories that are lost using paradigms that begin
exposures later.
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The lack of a standardized study design likely contributes significantly to the differing, and
sometimes opposing, results seen in BPA exposure studies. Upon first glance, the
inconsistencies in the field can be overwhelming and frustrating. However, when analogous
results are observed across distinct exposure paradigms, the robustness of these phenotypes
should be appreciated. The organ systems repeatedly reported to be affected by BPA should be
prioritized for comprehensive molecular assessments to understand the etiology of BPA
exposure-associated disease risk.
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Figure 1.1. Multigenerational and Transgenerational Inheritance. Exposure of a pregnant F0 dam
directly exposes both the F1 (exposed as developing fetus) and F2 (exposed as developing germ
cells of F1) generations. The first generation to experience no direct exposure to the original
stimulus (lightning bolt) from maternal exposure is the F3 generation. Paternal F0 exposure
directly exposes the F1 generation only (exposed as germ cells). Effects observed in the F2
generation are, therefore, considered transgenerational.
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CHAPTER 2. BPA AND BEHAVIOR
2.1. Background and study rationale
Mental health disorders are a major contributor to the global burden of disease. Of note,
the World Health Organization (WHO) selected depression as the theme for the 2017 World
Health Day campaign, bringing worldwide attention to this major global health concern (World
Health Organization (WHO) 2017). While genetic risk factors have been identified for mental
health disorders (Lohoff 2010), increased evidence in rodent and human studies has also
demonstrated a role for environmental influences on gene regulation and subsequent disease risk
(Delgado-Morales 2017). Additionally, accumulating evidence has linked fetal development with
behavioral and mental health outcomes in later life. The developing brain represents a particularly
vulnerable window to environmental injury given the incomplete formation of the blood-brain
barrier as well as blunted mechanisms for detoxifying exogenous chemicals (Choudhary et al.
2003b; de Wildt et al. 1999; Grandjean and Landrigan 2014).
The developing mammalian brain relies on sex steroid hormones to mediate the
composition of neural structures and connections that control a broad spectrum of cognitive and
behavioral outcomes in adulthood (Palanza et al. 2008). This organizational window in rodents,
which occurs just before and after birth, coincides with the second and third trimesters of
pregnancy in humans (McCarthy 2008). Additionally, a sexually dimorphic increase in estrogen in
the developing male brain, through the aromatization of gonadal testosterone, establishes malespecific neural circuitries in late gestation (Palanza et al. 2008). Disruptions in the hormonal
milieu during central nervous system (CNS) development, therefore, could impact brain function
in a sex-specific manner. Given the well-established role for sex steroid hormones in proper brain
development and function, endocrine disrupting chemicals (EDCs) have been proposed as
potential neurotoxicants (Grandjean and Landrigan 2014; McCarthy 2008).
One EDC of great interest given its ubiquitous presence in the environment is bisphenol
A (BPA), a chemical commonly used in the manufacturing of polycarbonate plastics and epoxy
resins (Calafat et al. 2008). Given its high production volume, urinary concentrations of BPA are
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detectable in virtually all sampled individuals in the United States (Calafat et al. 2008). As an
EDC, BPA is best studied for its estrogenic activity (Yamasaki et al. 2000), although additional
modes of BPA action including disrupted steroidogenesis have also been reported (Hong et al.
2016; Peretz and Flaws 2013). In humans, maternal exposure to BPA during gestation is
associated with altered behaviors in children, including sociability, anxiety, and depression in
some, but not all, studies (Mustieles et al. 2015). In rodent models, offspring gestationally and/or
lactationally exposed to BPA have also been reported to exhibit comparable behavioral deficits
(Palanza et al. 2016). Interestingly, the effects of BPA in both humans and rodents have
occasionally been reported to be sex-specific, although the affected sex varies by study
(Mustieles et al. 2015; Palanza et al. 2016). Unfortunately, within human epidemiological
investigations as well as experiments in rodent models, the heterogeneity in study design limits
comparative analyses. Nevertheless, the available literature suggests early life BPA exposure
can negatively impact behavior. The mechanisms underlying these changes, however, remain
unclear.
The hippocampus has long been associated with emotional regulation (Bannerman et al.
2014) and is susceptible to BPA. Morphologically, developmental exposure to BPA is associated
with impaired synaptogenesis and spinogenesis, two estrogen-mediated processes, that can
persist into adulthood (Kimura et al. 2016; Tiwari et al. 2015; Wang et al. 2014; Xu et al. 2014).
Molecular assessments of hippocampal gene expression changes following developmental BPA
exposure have, until recently, utilized candidate approaches (Chen et al. 2015; Kumar and
Thakur 2017a; Kundakovic et al. 2015; Wang et al. 2014; Xu et al. 2014). Given the pleiotropic
effects associated with BPA exposure, unbiased approaches have gained favor in the
identification of major pathways responsible for exposure-associated behavioral outcomes
(Arambula et al. 2016).
We previously reported whole brain-specific expression changes of clinically relevant
imprinted genes at midgestation in offspring exposed to BPA in utero (Susiarjo et al. 2013). The
postnatal molecular and behavioral consequences of exposure in our model, however, remain to
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be determined. Moreover, alterations in behavior have been reported to persist across multiple
generations of offspring directly exposed to BPA as well as generations that have received no
direct exposure, known as multi- and transgenerational effects, respectively (Wolstenholme et al.
2012, 2013). Other than social deficits, however, multi- and transgenerational behavioral
phenotypes associated with developmental BPA exposure have not been reported.
The aim of the present study was to assess multigenerational adult behavioral
consequences associated with developmental BPA exposure and to identify underlying molecular
dysregulation contributing to the behavioral changes. We identified male-specific disruptions in
affective behavior that were associated with reduced levels of the hippocampal serotonin and
systemic dehydroepiandrosterone, a neuroactive steroid in the sex steroidogenesis pathway. The
depressive-like phenotype in F1 generational males did not persist into the F2 generation.

2.2. Early life exposure to BPA induces depressive-like behavior in F1 generation
adult males
To determine the long-term behavioral consequences of developmental BPA exposure,
we performed a battery of behavior tests assaying a broad range of cognitive functions, starting in
F1 adult male mice. Previous reports from our lab have described male-specific effects of BPA
exposure on metabolic outcomes (Bansal et al. 2017; Susiarjo et al. 2015). Outcomes affected by
developmental BPA exposure in males were also assessed in females to determine sexspecificity.
Elevated Zero Maze (EZM) and Forced Swim Test (FST) assess anxiety and depressivelike behavior, respectively. There was no significant difference in the amount of time spent in the
open versus closed arms in EZM or the latency to enter the open arm (Figure 2.1,A-C),
suggesting levels of anxiety in BPA-exposed animals were comparable to controls in adulthood.
However, FST revealed a significant increase in the time spent immobile in F1 males exposed to
both lower (Figure 2.2A, d=1.12, p=0.01) and upper dose BPA (Figure 2.2A; d=1.25, p < 0.01),
suggestive of a depressive-like state. The enhanced immobility was not due to hypoactivity or
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general locomotor impairment in lower and upper dose BPA males as assessed by Hole Poke
(HP) (Figure 2.2B). When age-matched F1 adult females were assessed for depressive-like
behavior and general activity, no significant differences were observed across treatment groups
(Figure 2.2C and D). Stage of estrous did not affect the results of FST or HP in F1 females (data
not shown). Developmental BPA exposure in our model, therefore, is associated with depressivelike behavior in males only.
In addition to affective behavior, sociability has been commonly assessed following
developmental exposure to BPA (Dessì-Fulgheri et al. 2002; Jašarević et al. 2011; Porrini et al.
2005; Wolstenholme et al. 2011a). In our exposure model, when given the choice to interact with
a social or non-social object (mouse or rock, respectively), F1 adult male mice spent comparable
proportions of time interacting with the social object, regardless of treatment group (Figure 2.1D).
Thus, early life exposure to BPA in our model did not affect social behavior in F1 adult males.
Finally, the transmission of phenotypes across multiple generations has received
considerable attention in the developmental origins of health and disease (DOHaD) and
environmental exposure fields (Schmidt 2013). A limited number of multi- and transgenerational
rodent studies examining behavioral endpoints following developmental BPA exposure have been
reported, with a focus on altered sociability (Wolstenholme et al. 2012, 2013). To determine
whether BPA exposure-associated affective behavior is transmitted to subsequent generations,
we assessed FST and HP in F2 adult male offspring. F2 offspring were generated by breeding F1
exposed females to unexposed males. F2 adult males from BPA-exposed lineages had no
significant differences in FST or HP relative to control males (Figure 2.2E and F), limiting the
behavioral effects of developmental BPA exposure in our study to the F1 generation.

2.3. Behavioral changes following BPA exposure are independent of altered
maternal care
Disruptions to the maternal hormonal milieu by synthetic chemicals can compromise
maternal care and influence offspring behavior (Palanza et al. 2008). To assess the effect of BPA
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on maternal care, we analyzed both pup-directed and non-pup-directed behaviors of control- and
BPA-fed dams on the day of parturition. We first assessed nest quality using a previously
described scoring system that grades the nest based on its shape and height (Hess et al. 2008).
Exposure to BPA did not affect nest quality (Figure 2.3A). To determine whether BPA exposure
influenced pup-directed behaviors, we performed a pup retrieval test (Kuroda and Tsuneoka
2013; Myers et al. 1989). Two pups were separated from the cage and placed on the opposite
end relative to the nest. We then assessed the time for the F0 dam to carry the first pup, return
the first pup to the nest, and return all pups to the nest. Maternal exposure to dietary BPA did not
affect any of the pup retrieval endpoints (Figure 2.3B-D). Finally, we observed no significant
differences in the amount of time the F0 mother spent in the nest or the time spent actively
nesting (Figure 2.3E and F). Together, these results suggest that behavioral changes in BPAexposed offspring are not a secondary consequence of differences in maternal care.

2.4. Transcriptome analysis suggests early life exposure to BPA alters
neurotransmitter systems
To investigate potential mechanisms responsible for the BPA exposure-associated
behavioral outcomes, we used RNA-sequencing (RNA-seq) to analyze the whole hippocampal
transcriptome of control and upper dose BPA F1 adult male mice (n=4 per treatment group) in an
unbiased manner. The hippocampus is a critical brain region involved in the regulation of mood
(Bannerman et al. 2014). Approximately 92% of the trimmed reads aligned to the reference
sequences and the number of mapped reads ranged from 39-76 x 106 per sample (Table 2.1).
The Principal Component Analysis (PCA) plot generated by the expression profile of all genes did
not show a separation between control and upper dose BPA samples (Figure 2.4), indicating the
expression differences between the two groups are small compared to individual differences.
Despite the fact that gene expression fold changes were small (median fold change of all DEGs
was 1.59), we identified 110 differentially expressed genes (DEGs) of statistical significance using
a cutoff of FDR < 0.05 (Figure 2.4, Supplemental Dataset 1), and unsupervised clustering of the
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DEGs stratified animals by their expected treatment groups (Figure 2.5). Ingenuity Pathway
Analysis (IPA) revealed catecholamine biosynthesis and glutamate receptor signaling as top
affected canonical pathways (Figure 2.5B and C). The former pathway included an upregulated
gene, tyrosine hydroxylase (Th), which is a rate-limiting enzyme in catecholamine biosynthesis.
The latter pathway included a downregulated gene, ionotropic kainate glutamate receptor 5
(Grik5), which encodes a glutamate receptor subunit. The directionality of gene expression
changes following developmental BPA exposure for Th and Grik5 were confirmed by qRT-PCR
(Figure 2.5D).

2.5. Whole hippocampal serotonin levels are altered in BPA-exposed males
The monoamine deficiency hypothesis postulates that reduced levels of serotonin (5-HT),
norepinephrine (NE), and/or dopamine (DA) in the CNS are responsible for depression (Coppen
1967; Schildkraut 1965). In addition to monoamines, agents targeting amino acid
neurotransmitter systems such as glutamate have received increased attention as potential
therapeutic strategies for treating depression (Rakesh et al. 2017). Based on RNA-seq results
suggesting dysregulated catecholamine synthesis and amino acid neurotransmitter signaling
following developmental exposure to BPA, we next asked whether these gene expression
changes were sufficient to disrupt neurotransmitter levels. Using high-performance liquid
chromatography (HPLC), we observed a dose-dependent decrease in 5-HT (d=-0.89, p=0.04)
and the 5-HT metabolite 5-hydroxyindoleacetic acid (5-HIAA, d=-0.821, p=0.038) in upper dose
BPA-exposed adult male whole hippocampus while females were unaffected (Figure 2.6A and B).
The ratio of 5-HIAA to 5-HT, a measure of 5-HT degradation, was not significantly affected in
BPA-exposed males or females (Figure 2.6A and B).
Levels of the catecholamine neurotransmitters NE and DA were sex-specifically altered
by BPA exposure. DA was increased in lower dose BPA-exposed males (Figure 2.7A; d=0.32,
p=0.03), and NE was reduced in lower dose BPA-exposed females (Figure 2.7C; d=-0.52,
p=0.04). The dopamine metabolite homovanillic acid (HVA) was also reduced in lower dose BPA-
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exposed females (Figure 2.7C; d=-0.59, p=0.04). Finally, levels of amino acid transmitters
aspartate (Asp), glutamate (Glu), gamma-aminobutyric acid (GABA), and glutamine (Gln) were
not significantly different between the experimental groups in F1 males (Figure 2.7B and 4D).
However, in F1 females, GABA was reduced in lower dose hippocampus (Figure 2.7D; d=-0.99,
p=0.02). In sum, multiple neurotransmitters are dysregulated in a sex- and dose-specific manner
following BPA exposure. Specifically, in BPA-exposed males, serotonin and catecholamine
neurotransmitters appear to be more susceptible to disruption by early life exposure to BPA than
amino acid neurotransmitters.

2.6. Fluoxetine rescues lower but not upper dose BPA exposure-associated
behavior
Antidepressant drugs are a mainstay of treatment in depression, with selective serotonin
reuptake inhibitors (SSRIs) representing the most commonly prescribed class of antidepressants
in humans (Cipriani et al. 2012; Nautiyal and Hen 2017). Fluoxetine (FLX), also known by the
trade name Prozac, was among the first SSRIs used to treat depression (Nautiyal and Hen 2017).
Fluoxetine allows for the targeted accumulation of serotonin in the synapse and provides
increased opportunities for the transmitter to activate its downstream signaling pathways
(Nautiyal and Hen 2017). Given the male-specific behavioral phenotype and reduction in
hippocampal serotonin, we next asked whether the behavioral consequences of early life
exposure to BPA could be rescued with FLX. Saline or 20 mg/kg bw of FLX was administered
intraperitoneally to F1 adult males 30 minutes prior to FST. While lower dose BPA-exposed
males responded to FLX administration (Figure 2.6C; d=-1.32, p<0.01), upper dose males did not
exhibit significant improvements in FST (Figure 2.6C), suggestive of treatment resistance. These
results also suggest dose-specific molecular changes underlying the depressive-like phenotype in
BPA-exposed F1 male offspring.
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2.7. Circulating neuroactive steroids are depleted in BPA-exposed F1 adult male
mice
In addition to neurotransmitter system dysfunction, hormonal imbalances are a wellestablished biological factor in the etiology of depression (Xu et al. 2015). Importantly, various
intermediate hormones in the sex steroidogenesis pathway also function as neuroactive steroids
and have potential roles in mood regulation (Maninger et al. 2009). Using LC-HRMS, we assayed
circulating DHEA, testosterone, and estrone in F1 adult male serum to determine whether
differences in systemic neuroactive steroids could be contributing to the depressive-like
phenotype. Estrone was below the limit of quantification for all samples (data not shown), while
testosterone was not significantly different across treatment groups (Figure 2.8A). A KruskalWallis H test revealed a significant difference in serum DHEA (H(2 d.f.)=6.50, p=0.039, η2=0.12).
A Dunn-Bonferroni post hoc method subsequently identified a significant reduction in serum
DHEA in lower dose BPA-exposed males (Fig. 2.8B; p=0.015). Whole hippocampal tissues
showed similar trends of reduced testosterone and DHEA, albeit not statistically significant
(Figure 2.8C and D). No gross differences in testis weight, the primary location for DHEA and
testosterone synthesis in rodents (Maninger et al. 2009), were observed across treatment groups
(Figure 2.8C). The disruption of neuroactive steroids following developmental BPA exposure may,
therefore, also be contributing to the observed depressive-like state in BPA-exposed F1 adult
males.

2.8. Discussion
In this study, we investigated the underlying molecular changes associated with altered
behavior following chronic, in utero and lactational exposure to the endocrine disruptor BPA. The
proper action of sex steroids during a restricted developmental window, just before and just after
birth in rodents, is required for the effective induction of behaviors in adulthood (McCarthy 2008).
F1 adult male offspring developmentally exposed to BPA were significantly more immobile in the
FST compared to sex-matched controls, suggestive of a depressive-like state. Importantly, these
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effects were not due to differences in maternal care, although other exposure models have
reported effects of BPA on parental care (Kundakovic et al. 2013). In this study, maternal care
assessments are limited to the day of parturition. Future studies should extend to behaviors such
as licking and grooming as well as specific types of nursing behavior (e.g. arched back, flat
posture), and all observations should be repeated across multiple days. The observed
depressive-like phenotype also occurred independent of an anxiety phenotype, which has been
reported in some (Wolstenholme et al. 2011a), but not all (Rebuli et al. 2015; Williams et al. 2013;
Wolstenholme et al. 2011b), studies. While BPA has been reported to induce transgenerational
alterations in social behavior (Wolstenholme et al. 2012, 2013), affective behavioral changes in
our study were limited to the F1 generation. The previously mentioned inconsistencies and
others, such as the direction and sex-specificity of behavioral changes, associated with
developmental BPA exposure may be attributed to heterogeneity in study design. This includes
factors such as rodent strain, dose of BPA, route and window of exposure, age of offspring at
time of assessment, as well as how the behavior tests are conducted (e.g. phase of light/dark
cycle). Regardless, it is clear that the period of neurodevelopment represents a vulnerable
window to environmental perturbations that have lasting effects on behavior.
Given the depressive-like phenotype in F1 adult males, we performed RNA-seq on the
adult male whole hippocampus, an established brain region involved in mood regulation
(Bannerman et al. 2014). This study is the first to report transcriptome-wide changes in the adult
murine hippocampus following early life exposure to BPA. In another RNA-seq study using a
different developmental BPA exposure model, only 10 genes were found to be differentially
expressed in the male newborn rat hippocampus compared to 1000+ genes in the hypothalamus
(Arambula et al. 2016), suggesting differential susceptibility of brain regions to BPA. Therefore,
studies in other brain regions with roles in mood regulation, such as the amygdala, may provide
additional mechanistic insight into our BPA exposure-associated behavioral changes. Of the 10
DEGs reported in the neonatal rat hippocampus by Arambula and colleagues (Arambula et al.
2016), none overlapped with our dataset, which is unsurprising given the differences in species
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and assayed developmental stage. Differences aside, the greater number and distinct set of
DEGs in our adult hippocampal data set suggest additional changes in gene expression that
become apparent following the induction of circulating sex steroid hormones. The directionality of
gene expression changes from our RNA-seq study was validated by qRT-PCR; given the
variability in response to developmental BPA exposure, this may have contributed to the lack of
statistically significant differences in gene expression in our qRT-PCR studies (Fig. 2.5).
Pathway analysis of the DEGs identified neurotransmitter systems as top dysregulated
pathways in the BPA-exposed adult whole hippocampus. Given the autoregulatory nature of
neurotransmission (Nautiyal and Hen 2017), we hypothesized neurotransmitter levels themselves
may be affected in BPA-exposed male mice. Hippocampal neurotransmitter analysis by HPLC
identified sex- and dose-specific differences in serotonin, dopamine, norepinephrine, and GABA
in the adult male and female hippocampus (Figures 2.6 and 2.7). Altered serotonin levels were of
particular interest given the sex-specificity in this study as well as previous work from our lab
reporting effects of BPA exposure on tryptophan metabolism, the precursor of 5-HT (Susiarjo et
al. 2017). One other report has assessed neurotransmitter levels in mice perinatally exposed to
BPA (250 ng/kg/d), from gestation day 10 to postnatal day 20 (Matsuda et al. 2013). While adult
female mice demonstrated a significant decrease in hippocampal 5-HT turnover in their study,
male hippocampal 5-HT levels were not affected (Matsuda et al. 2013). No assessments of
affective behavior, however, were performed. In our study, both lower dose and upper dose BPA
males exhibited increased depressive-like behavior and decreases in 5-HT, although reductions
in 5-HT may be occurring through distinct mechanisms at each dose. It is tempting to speculate
that the slight reduction in 5-HT in lower dose males in our study may be due to increased
turnover, as shown by a moderately increased ratio of 5-HIAA to 5-HT (Figure 2.6A). In contrast,
decreased levels of 5-HT and 5-HIAA in the upper dose animals (Figure 2.6A) suggests a general
depletion of 5-HT in the hippocampus. Consistent with previous reports published by our lab, this
result suggests that functional outcomes following developmental BPA exposure are driven by
distinct, dose-specific molecular changes (Bansal et al. 2017; Susiarjo et al. 2017). Future
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assessments in brain regions that synthesize the respective neurotransmitters (e.g. dorsal raphe
nucleus for 5-HT) will also help to more precisely identify the mechanisms of BPA exposureassociated neurotransmitter disruption.
Given the prominent role of serotonergic dysfunction in the etiology of depression
(Nautiyal and Hen 2017), we asked whether the depressive-like state in BPA-exposed F1 males
could be rescued by an anti-depressant targeting the serotonergic system. Interestingly,
administration of 20 mg/kg bw FLX was sufficient to rescue the depressive-like phenotype in
lower dose male mice while upper dose mice did not display significant improvement in the FST
(Fig. 2.6C), again demonstrating dose-specific effects. In females, changes in neurotransmitter
levels in the absence of a depressive-like phenotype could be due to insufficient changes in
magnitude to elicit a detectable change in physiology. Alternatively, the changes in femalespecific neurotransmitters could be associated with other behavioral outcomes that were not
assessed in this study.
To determine other potential factors associated with the depressive-like phenotype in F1
adult males developmentally exposed to BPA, we asked whether levels of steroids in the sex
steroidogenesis pathway were affected by developmental BPA exposure. Hormonal imbalance
has been associated with affective disorders in both humans and rodents. Hypogonadal men
have been reported to be at increased risk for depression, and castration in rodent models
increases depressive-like behavior (McHenry et al. 2014). Previous studies in gonadal tissues
have also reported suppression of critical enzymes in the steroidogenesis pathway following early
life exposure to BPA (Hong et al. 2016; Peretz and Flaws 2013). In our study, BPA exposure was
associated with a significant reduction in systemic DHEA levels in lower dose males while
testosterone was not significantly different from controls at either dose (Fig. 4A and 4B). A similar
trend in reduced steroid levels was observed directly in hippocampal tissue (Fig. 4C and 4D).
Although steroid levels in serum and tissue in our study were variable, the average values were
comparable to previous reports in unexposed animals (Hojo et al. 2011; Nilsson et al. 2015).
Average serum testosterone levels in our study were slightly lower than Nilsson et al., at 5546
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pg/mL in control males compared to 8235 pg/mL. On the other hand, average serum DHEA
values in our study was higher (1842 pg/mL in control males) than DHEA levels reported by
Nilsson and colleagues (<50 pg/mL). Discrepancies across studies are likely due to differences in
methodology (Nilsson et al. 2015).
Because the hippocampus has been reported to be capable of synthesizing its own
neuroactive steroids (Maninger et al. 2009; Tuem and Atey 2017), it is possible that the brain
recognizes and compensates, somewhat, for the reduction in steroids from peripheral sources.
Although not significantly different, the depleted hippocampal steroids in combination with the
depleted neurotransmitters may be exacerbating the behavioral change following developmental
exposure to BPA. While estrogen and testosterone are well-established neuroactive steroids and
often the primary steroids of interest in EDC studies, upstream steroids like DHEA have been
reported to exert distinct neurobiological activities. In addition to its neuroprotective and
neurogenic effects, DHEA can modulate neurotransmitter function (Maninger et al. 2009). DHEA
has been reported to be involved in catecholamine synthesis and secretion and glutamate
receptor signaling, two pathways identified in our hippocampal RNA-seq data, as well as
serotonin release (Lazaridis et al. 2011; Maninger et al. 2009; Tuem and Atey 2017). Although
the genes encoding sex steroidogenesis enzymes did not show significant expression differences
by RNA-seq, it is possible that their abundance and/or activity at the translational level could be
affected by early life BPA exposure. In humans, low circulating levels of DHEA have been
associated with increased ratings of depressed mood in some, but not all, studies (Maninger et al.
2009). Exogenous administration of DHEA, however, has consistently been reported to exert
antidepressant effects in humans (Maninger et al. 2009), suggesting supplementation of DHEA
aids in regulating mood via additional mechanisms beyond just correcting for deficiencies in
systemic DHEA. Whether exogenous steroid supplementation in our animal model would rescue
the depressive-like phenotype, and how the effects would compare to anti-depressant therapy,
remains to be determined.
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Given the ability of BPA to mimic estrogen (Xin et al. 2015; Yamasaki et al. 2000), the
involvement of classical and non-classical estrogen receptors (ERs) in the sex-specific depletion
of hippocampal 5-HT following developmental BPA exposure also remains to be determined. It is
known that estrogen can alter levels of 5-HT as well as regulate the number and function of its
receptors (Kajta et al. 2017; Ryan and Ancelin 2012), suggesting BPA could be acting through
ERs to mediate its effects. Although BPA can bind to the classical ERs, ERα and ERβ, its affinity
is lower than that of endogenous estrogen (Acconcia et al. 2015), suggesting classical ERindependent mechanisms of BPA action may also contribute to the observed phenotypes. Nonclassical ERs such as the membrane-bound G protein-coupled receptor (GPER) have also been
reported to modulate serotonergic function (Kajta et al. 2017) and BPA is capable of activating
GPER-mediated downstream pathways in vitro. Additionally, BPA has been reported to bind to
GPER with greater affinity than either ERα or ERβ (Fitzgerald et al. 2015; Xu et al. 2017). Of
note, GPER knockout mice exhibit impaired affect and stress control, with more robust effects in
male than female mice (Kastenberger and Schwarzer 2014). Although the transcripts for the
classical and non-classical ERs were not shown to be significantly affected by BPA in our
hippocampal RNA-seq dataset, it is possible that their regulation is also being affected at the
translational level.
Finally, it will be worthwhile to determine if behavioral changes are detectable earlier than
adulthood in our model. Transient developmental disruptions of serotonergic function using
conditional knockout strategies and pharmacological inhibition have been shown to exert longterm consequences on adult affective behavior (Ansorge 2004; Gross et al. 2002; Heisler et al.
1998; Toth 2003). Some reports suggest that the affective behavioral impairments following these
disruptions impact males more than females (Heisler et al. 1998), although others report no
apparent sex differences (Toth 2003). Assessing affective behavioral outcomes in animals prior to
puberty will also provide insight into the requirement for circulating sex steroids in the detection of
sex-specific affective behavioral changes.
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In this study, we show that early life exposure to BPA, at levels representative of human
exposure, elicits persistent, sex-specific behavioral consequences in adulthood. F1 male offspring
of dams exposed to BPA from preconception until weaning demonstrate increased depressivelike behavior. This behavioral change is not due to altered maternal care and is not transmitted
through the maternal germline to the F2 generation. Male-specific depletions in hippocampal
serotonin and systemic neuroactive steroids may be responsible for the observed behavioral
changes in the F1 generation. Understanding the effects of EDCs in early mammalian
development and their mechanism(s) of action on a local and genome-wide scale will allow for
improved assessments of their health risk to the general population and may aid in future
regulatory decision-making. Overall, this study highlights the susceptibility of neurodevelopment
to environmental exposures and its potential role in the genesis of mental health disorders.
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Table 2.1. RNA-sequencing sample summary.

Raw
read pairs
Trimmed
read pairs
Unique,
concordantly
aligned read
pairs
Read pairs
assigned to
gene

C1
(BRSEQ08)

C2
(BRSEQ03)

C3
(BRSEQ10)

C4
(BRSEQ05)

U1
(BRSEQ04)

U2
(BRSEQ09)

67,766,459

60,928,937

53,604,624

46,075,887

72,924,084

88,328,234

71,414,288

73,366,765

63,780,848

57,284,874

49,899,408

42,851,093

68,122,324

83,162,975

67,145,552

68,976,461

58,756,887

52,734,676

45,303,183

39,468,213

62,293,932

76,646,792

61,673,871

63,613,361

40,793,192

36,280,700

31,118,450

27,135,071

43,572,542

54,013,884

43,119,986

44,002,785

Abbreviations: C, control; U, upper dose BPA
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U3
(BRSEQ12)

U4
(BRSEQ11)

Figure 2.1. Anxiety and sociability tests in F1 male offspring. Anxiety and sociability were not
affected in F1 males following developmental exposure to BPA. Elevated zero maze (EZM)
endpoints included (A) time spent in open arms of the maze, (B) time spent in closed arms of the
maze, and (C) latency to enter the open arm of the maze. Increased time in the open arms is
indicative of decreased anxiety. (D) Social choice, a measure of sociability, assesses the
proportion of time spent interacting with a social or nonsocial cue. All endpoints were comparable
across treatment groups. Number of offspring and number of litters denoted below each
treatment group; animals from one exposure cohort. The adult animal was used as the unit of
measurement. Bars represent mean ± SEM. Linear mixed effects modeling with correction for
multiple comparisons.
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Figure 2.2. Depressive-like behavior and activity tests. Developmental exposure to BPA
induces sex- and generation-specific affective behavior in adulthood. (A) Forced Swim Test (FST)
and (B) Hole Poke (HP) in F1 males (circles). (C) FST and (D) HP in F1 adult females (triangles)
demonstrate no significant differences across treatment groups. (E) FST and (F) HP in F2 adult
males (diamonds). Behavior changes in F1 generation males did not persist to the F2 generation.
Number of offspring and number of litters denoted below each treatment group from three cohorts
of exposures. The adult animal was used as the unit of measurement. * p < 0.05; ** p < 0.01
compared to sex-matched controls. Bars represent mean ± SEM. Linear mixed effects modeling
with correction for multiple comparisons.
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Figure 2.3. Maternal care assessments. Maternal care is not affected by BPA exposure. (A)
Mean nest score to assess non-pup-directed maternal behavior. Latency to (B) carry first pup and
(C) bring the first pup back to the nest following physical separation. (D) Total time to retrieve
both pups back to the nest. The F0 dam was used as the unit of measurement; animals from two
exposure cohorts. (E) Percent of total testing time spent in the nest, regardless of behavior
exhibited while in the nest. (F) Percent of total testing time when F0 dam is engaged in nest
building. Bars represent mean ± SEM. Linear mixed effects modeling with correction for multiple
comparisons.
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Figure 2.4. RNA-sequencing PCA and MA plots. RNA sequencing analysis in adult
hippocampus. (A) PCA plot of four Control (C, blue dot) and four Upper dose BPA (U, red dot)
adult hippocampal samples from one exposure cohort; normalized by DESeq. (B) MA plot
showing differentially expressed genes (DEGs) in upper dose BPA adult male hippocampus
relative to control. 110 DEGs (98 upregulated, 12 downregulated), shown in red, were identified.
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Figure 2.5. RNA-sequencing heat map and ingenuity pathway analysis (IPA). RNAsequencing reveals disrupted hippocampal neurotransmitter systems following developmental
BPA exposure. (A) Hierarchically clustered heat map of 110 differentially expressed genes
(DEGs) from RNA-sequencing of control (abbreviation: C) and upper dose (abbreviation: U) BPAtreated F1 adult male hippocampus. N = 4 males per treatment group (from independent litters)
from one exposure cohort. The expression level of 98 upregulated and 12 downregulated genes
shown as Log2 of sequence read counts per million (CPM). A complete list of all genes can be
found in Supplemental Dataset 1. Top canonical pathways by IPA for (B) upregulated and (C)
downregulated DEGs and affected genes. (D) qRT-PCR validation studies for tyrosine
hydroxylase (Th) and ionotropic kainate glutamate receptor 5 (Grik5) in F1 adult male
hippocampus. Fold changes by RNA-seq for Th and Grik5 in upper dose BPA-exposed males
were 1.4 and 0.69, respectively. By qRT-PCR, fold changes in upper dose were 1.24 and 0.74,
respectively. Number of offspring and number of litters denoted below each treatment group from
two cohorts of exposures. The adult animal was used as the unit of measurement. Bars represent
mean ± SEM. Linear mixed effects modeling with correction for multiple comparisons.

39

Figure 2.6. Hippocampal serotonin and rescue experiment. Developmental BPA exposure
reduces hippocampal serotonin in males and depressive-like behavior is rescued by
antidepressant targeting the serotonergic system. F1 adult (A) male (circles) and (B) female
(triangles) hippocampal serotonin (5-HT), 5-hydroxyindoleacetic acid (5-HIAA), and the ratio as a
measure of 5-HT turnover. In (A) and (B), legends below graphs correspond to number of adult
offspring and litters (in parentheses) analyzed for each neurotransmitter and metabolite.
Neurotransmitter analyses conducted on animals from three cohorts. (C) Saline (SAL, circles) or
fluoxetine (FLX, squares) was administered in F1 adult males 30 minutes prior to FST. Number of
offspring and number of litters denoted below each treatment group, from one exposure cohort. In
all panels, the adult animal was used as the unit of measurement. * p < 0.05; compared to sexmatched controls. Bars represent mean ± SEM. Linear mixed effects modeling with correction for
multiple comparisons.
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Figure 2.7. Biogenic amine and amino acid neurotransmitter levels. Neurotransmitters in
adult F1 male (circles) and female (triangles) mice developmentally exposed to BPA. F1 male (A)
biogenic amine and (B) amino acid neurotransmitter abundance relative to controls. F1 female
(C) biogenic amine and (D) amino acid neurotransmitter abundance relative to controls. Legends
below graphs correspond to number of adult offspring and litters (in parentheses) analyzed for
each neurotransmitter and metabolite across three exposure cohorts. 3 samples for DOPAC (1
lower dose male, 1 upper dose male, and 1 control female), 3 samples for NE (2 control female, 1
upper dose female), and 1 sample for DA (1 control male) were not resolved and excluded from
analysis prior to unblinding. The adult animal was used as the unit of measurement. Linear mixed
effects modeling with correction for multiple comparisons. * p < 0.05; compared to sex-matched
controls. Graphs display mean ± SEM.
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Figure 2.8. Sex steroid and testis weights. Circulating neuroactive steroids are depleted in
BPA-exposed male mice. Serum (A) testosterone and (B) dehydroepiandrosterone (DHEA)
measured by high resolution mass spectrometry from five exposure cohorts. DHEA was
significantly reduced in upper dose BPA male serum. Hippocampal (C) testosterone and (D)
DHEA from one exposure cohort show similar trends to serum. (E) Testis weights, from one
exposure cohort, were not significantly different across treatment groups. Number of offspring
and number of litters denoted below each treatment group. The adult offspring was used as the
unit of measurement. For (A-D), Kruskal-Wallis H test followed by Dunn-Bonferroni post-hoc test.
For (E), linear mixed effects model with correction for multiple comparisons. * p < 0.05 compared
to sex-matched controls. Lines denote mean ± SEM.
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CHAPTER 3 BPA AND METABOLISM
3.1 Background and study rationale
Previous work in our lab demonstrated misregulation of imprinted gene expression in the
whole, midgestation (E9.5) embryo following in utero exposure to BPA (Susiarjo et al. 2013). One
misregulated imprinted gene of particular interest was the insulin-like growth factor 2 (Igf2) gene.
Early life exposure to BPA was associated with increased DNA methylation at Igf2 differentially
methylated region (DMR) 1 and increased total Igf2 mRNA expression (Susiarjo et al. 2013). Igf2
not only plays a critical role in growth promotion during development (Barlow and Bartolomei
2014), but its misregulation is also associated with impaired metabolic homeostasis (Ács et al.
2017; Jones et al. 2001; Navarro et al. 2017). Therefore, we asked whether disrupted Igf2
expression in early life could be associated with changes in metabolic health in adulthood.
Furthermore, we investigated the persistence of a metabolic phenotype to the subsequent, F2,
generation through the maternal germline. This work was published in Endocrinology in 2015
(Susiarjo et al. 2015).

3.2 Developmental BPA exposure elicits male-specific metabolic defects in
adulthood
To assess the effects of developmental BPA exposure on metabolic health, we first
recorded weekly body weights of F1 offspring beginning at birth. Interestingly, lower dose BPAexposed male mice demonstrated reduced birth weight, but then exhibited accelerated growth
and overcame weight deficits by four weeks of age (Figure 3.1). In humans, this growth trajectory
pattern has been associated with the development of obesity and glucose intolerance in
adulthood (Mcmillen and Robinson 2005). No other significant differences in body weight were
observed in F1 generation offspring until after PND98, when male mice developmentally exposed
to BPA began to display increased body weight relative to sex-matched controls (Susiarjo et al.
2015). Female mice exposed to BPA, on the other hand, did not show significant differences in
body weight relative to controls.
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Given the increased body weight phenotype in adulthood, we next asked how
developmental exposure to BPA affected body composition in F1 male and female mice. To this
end, we performed dual energy x-ray absorptiometry (DEXA) to determine percent body fat. Of
note, DEXA scans are also frequently used in clinical settings to assess areal bone mineral
density and subsequent fracture risk (Blake and Fogelman 2007). Consistent with the observed
sex-specific body weight phenotype, only F1 male offspring displayed significant increases in
percent body fat, while females were not affected (Figure 3.1). Bone mineral density and bone
mineral content were also significantly reduced in the upper dose male mice (Figure 3.1),
suggesting developmental BPA exposure may increase fracture risk in adult male mice. Thus,
additional assessments in bone were warranted and conducted in collaboration with Karl Jepsen
and Lauren Smith (University of Michigan). This work is discussed in Chapter 4.
Increased body fat is often associated with the inability to regulate blood glucose (Bano
2013). Therefore, we performed intraperitoneal (i.p.) glucose tolerance tests (GTT) to assess
glucose metabolism. Lower and upper dose BPA-exposed males demonstrated increased
glucose area under the curve (AUC), indicative of hyperglycemia, although this was only
statistically significant in the upper dose BPA exposure group (Figure 3.2). To further explore
whether the glucose intolerance phenotype was due to peripheral insulin resistance or impaired
glucose-stimulated insulin secretion, we measured basal insulin release and glucose-stimulated
insulin secretion, respectively. Interestingly, the pancreatic phenotypes associated with BPA
exposure were dose-dependent: F1 male mice exposed to upper dose BPA demonstrated
increased levels of basal insulin release relative to sex-matched controls, indicative of insulin
resistance (Figure 3.2). In contrast, lower dose BPA-exposed animals demonstrated comparable
levels of insulin release at baseline but significantly impaired glucose-stimulated insulin secretion
(Figure 3.2). In sum, early life exposure to BPA is associated with sex-specific metabolic
impairments. The underlying physiological changes contributing to the metabolic defects in F1
adult male mice, however, appear to be dose-specific.
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3.3. Partial multigenerational transmission of BPA exposure-associated changes
in F2 male offspring
In our preconception to lactation exposure model, not only are the F0 dam and F1 fetus
directly exposed to BPA, but the F2 generation is also as the developing germline of the F1
offspring. In vitro studies have reported germ cell susceptibility to BPA exposure (Chao et al.
2012; Zhang et al. 2012), suggesting the health of the F2 generation may also be at risk following
early life BPA exposure. To generate F2 offspring, F1 virgin females exposed to BPA were mated
to unexposed males to assess multigenerational transmission through the maternal germline. In
utero-exposed males were not used for mating in this study, in order to limit the potential
contribution of altered paternal metabolic milieu in our multigenerational transmission model.
Depending on the endpoint, females were either mated to C57BL/6J males or the
previously described B6(CAST7) strain (Mann et al. 2003). The B6(CAST7) strain of mouse is of
C57BL/6J background with the exception of chromosome 7, which comes from the evolutionarily
divergent Mus musculus castaneus strain. Single nucleotide polymorphisms between the two
strains of mice allow for the allelic distinction of transcript origin in hybrid offspring using
restriction fragment length polymorphism (RFLP)-based approaches.
Similar to the previously published paper assessing BPA exposure-associated effects on
imprinted gene expression (Susiarjo et al. 2013), we first assessed imprinted gene status in F2
hybrid, midgestation embryos. Unlike the F1 generation embryos, F2 generation embryos did not
exhibit differences in allelic expression of Igf2 (data not shown). However, total mRNA expression
remained elevated in upper dose F2 male fetuses (Figure 3.3), similar to what was observed in
F1 embryos (Susiarjo et al. 2013). When we assessed DNA methylation levels at the Igf2
differentially methylated region (DMR) 1, we did not observe a significant difference in average
DNA methylation at the DMR. Upon further analysis by individual CpGs, however, a slight
increase in DNA methylation was observed at CpG site 2 in F2 BPA-exposed male embryos
(Susiarjo et al. 2015). Therefore, BPA exposure-associated changes in imprinted gene
expression are partially transmitted to F2 generation males.
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Given the persistent increase in total Igf2 expression, we aged a group of C57BL/6J x
C57BL/6J F2 offspring to assess metabolic health in adulthood. Unlike the F1 generation, weekly
body weights were not significantly different between treated mice and their respective sexmatched control groups (data not shown). However, DEXA and GTT results revealed persistent
body fat and glucose intolerance phenotypes, respectively, in F2 adult male mice (Figure 3.4).
Consistent with the F1 generation, female offspring were not affected at any assessed
parameters. F2 upper dose male mice did not demonstrate increased basal insulin levels like the
F1 generation males, but F2 lower dose males display the same impairment in glucosestimulated insulin secretion observed in the previous generation (Figure 3.4). Therefore, most
physiological changes associated with developmental BPA exposure were transmitted to the F2
generation in a sex-specific manner.

3.4. Overexpression of Igf2 phenocopies metabolic defects associated with
developmental BPA exposure
To determine whether increased expression of Igf2 could be driving the metabolic
changes in BPA-exposed mice, we utilized a previously established genetic mouse model of Igf2
overexpression (Thorvaldsen et al. 2002, 2006). The H19∆3.8 mouse carries a 3.8 kb deletion at
the H19/Igf2 imprinted gene cluster, which includes the cis-acting regulatory region known as
imprinting control region (ICR). When imprinting mechanisms are intact, the ICR on the maternal
allele is typically unmethylated, allowing the methylation-sensitive transcription factor CTCF to
bind (Thorvaldsen et al. 2002, 2006). CTCF acts as an insulator, blocking shared downstream
enhancers from interacting with Igf2, resulting in maternal H19 expression and transcriptional
repression of Igf2 (Thorvaldsen et al. 2002, 2006). When the 3.8 kb deletion is inherited
maternally, loss of CTCF binding and its associated insulator function allow for the shared
enhancers to now access and activate the normally silenced maternal Igf2 allele, resulting in
biallelic, overexpressed Igf2 (2-2.5 fold higher levels of Igf2 at E9.5) (Thorvaldsen et al. 2002,
2006). The metabolic changes observed in BPA-exposed male mice were phenocopied in the
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genetically engineered male mice with Igf2 overexpression (Figure 3.5). Limitations of this genetic
model include the concurrent decrease in H19 expression and overexpression of Igf2 in female
offspring in the absence of a metabolic phenotype. This data, therefore, suggests that Igf2 could
be partially responsible for the metabolic phenotypes observed in BPA-exposed offspring but is
not the sole contributor to the phenotype.

3.5. BPA exposure affects maternal metabolic health in F0, but not F1, dams
Finally, previous work has suggested that BPA is capable of disrupting maternal
metabolic health, inducing gestational diabetes (Alonso-Magdalena et al. 2010). Reports in
humans and rodents have demonstrated links between impaired maternal metabolic health and
metabolic deficits in offspring (Li et al. 2017; Mitanchez and Chavatte-Palmer 2018). To
determine the extent to which gestational diabetes may be contributing to the observed metabolic
defects in F1 and F2 offspring, we performed GTTs in gestation day 16.5-17.5 F0 and F1 dams
(Figure 3.6). Consistent with previous reports of BPA exposure-associated gestational diabetes in
F0 dams (Alonso-Magdalena et al. 2010), F0 lower and upper dose dams in our exposure model
were glucose intolerant during pregnancy (Figure 3.6). Therefore, impaired maternal metabolic
health may be contributing to the observed metabolic changes in F1 adult offspring. In contrast to
the F0 dams, glucose AUCs in the F1 dams were comparable to controls, suggesting the
metabolic defects in F2 offspring are independent of altered glucose homeostasis in the dam
during gestation.

3.6. Discussion
In our model, developmental exposure to BPA was associated with sex- and dosespecific changes across two generations of offspring. F1 and F2 generation male mice had higher
percentages of body fat and were glucose intolerant relative to controls. Female offspring, on the
other hand, were not affected. While reports of sex-specific effects following developmental EDC
exposure continue to increase, the susceptible sex varies (Palanza et al. 2016; Xin et al. 2015). In
our exposure model, the physiological endpoints assessed thus far all demonstrate male-specific
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susceptibility to BPA. At the time this story (Susiarjo et al. 2015) was published, we had not
assessed circulating sex steroid hormone levels in BPA-exposed male and female mice. The later
finding of reduced dehydroepiandrosterone (DHEA) and testosterone in our BPA-exposed F1
adult male mice (Chapter 2) may be a key factor in the manifestation of male-specific metabolic
complications. Clinical reports have correlated low testosterone with both obesity and insulin
resistance (Bianchi and Locatelli 2018; Meyer and Wittert 2018). Our hypothesis of sex steroid
hormone-mediated effects would be further strengthened if GTT and/or DEXA scans in juvenile
mice, prior to the onset of puberty, were comparable across sex-matched treatment groups.
Whether DHEA and testosterone are similarly reduced in the F2 males remains to be determined.
The nonmonotonic dose-response of BPA and other EDCs is well-established (Vandenberg et al.
2012), suggesting different pathways or combinations of pathways could be mediating EDCinduced effects at specific doses. In line with this, we observed dose-specific changes in basal
and glucose-stimulated insulin release, both of which were associated with impaired glucose
homeostasis.
While other studies have previously reported metabolic defects in offspring gestationally
exposed to BPA (Li et al. 2014; Liu et al. 2013; Ma et al. 2013a; van Esterik et al. 2014), our
study is the first to demonstrate multigenerational transmission of metabolic defects through the
maternal germline. Only one other study has reported on multigenerational metabolic
assessments in a gestational BPA exposure model (Li et al. 2014). In contrast to our study, Li and
colleagues assessed paternal transmission of the phenotype. F0 Sprague Dawley female rats
were administered 40 µg BPA/kg bw/d by gavage from conception until weaning age (Li et al.
2014). F1 male rats developmentally exposed to BPA were subsequently mated to unexposed
females to generate F2 offspring. Consistent with our study, F2 generation adult male offspring
displayed glucose intolerance and insulin resistance (Li et al. 2014). Unfortunately, only F2 male
offspring were assessed for metabolic defects; therefore, it is unclear whether this effect was sexspecific (Li et al. 2014). Data from both studies suggest that the male and female germlines are
both susceptible to environmental perturbations, and offspring may be at greater risk of
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developing metabolic disorders. Whether the phenotypes in offspring are exacerbated when both
parents have been developmentally exposed to BPA remains to be determined. Furthermore,
whether the metabolic phenotypes in our exposure model can be further transmitted to a
generation with no direct exposure (F3 generation) to BPA remain to be determined. In our
exposure model, effects that persist to the F3 generation would be considered transgenerational.
Given the strong interconnectedness of the maternal-fetal unit during pregnancy, it is
critical to consider the health status of the mother when assessing metabolic outcomes in
offspring. Although F0 dams develop gestational glucose intolerance, F1 dams do not; therefore,
the metabolic changes in the F1, but not F2, offspring could be influenced by altered maternal
metabolic milieu. A more comprehensive study of the F0 maternal and/or F1 fetal metabolome
will be critical to our understanding of the global metabolic responses to BPA. The unbiased
determination of overrepresented pathways disrupted by BPA exposure will allow for targeted
analyses of pathways more likely to be driving the exposure-induced phenotypes.
Epigenetic dysregulation in early life may also explain the persistent metabolic phenotype
observed in F1 and F2 BPA-exposed males. More specifically, altered DNA methylation and
improper expression of Igf2 in both generations of mice may contribute to the metabolic
phenotype observed in offspring in our BPA exposure model. In humans, Beckwith-Wiedemann
Syndrome patients with Igf2 overexpression, due to increased DNA methylation on the maternal
H19/Igf2 ICR, can also exhibit early-onset obesity (Martos-Moreno et al. 2014). Periconceptual
exposure to famine during the Dutch Hunger Winter was also associated with persistent loss of
DNA methylation at Igf2 DMR in adult blood, irrespective of sex (Heijmans et al. 2008; Schmidt
2013). Total Igf2 expression was, unfortunately, not assessed. Concurrently, long-term
physiological consequences in offspring exposed to famine in utero include reduced glucose
tolerance and obesity (Roseboom et al. 2006). Evidence in rodents and humans, therefore,
suggest that the proper epigenetic regulation and expression of Igf2 is susceptible to
environmental perturbations. It is not known in our model whether Igf2 overexpression persists
across the lifespan and will require further study. Additionally, future work involving more global
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approaches to assess BPA exposure-associated gene expression and epigenetic changes will
provide an unbiased view of the most susceptible genes, pathways, and/or networks that may be
contributing to the observed metabolic changes.
In sum, we demonstrated increased metabolic health risks in fetuses and their offspring
following gestational and lactational exposure to BPA at levels representative of human exposure.
Both epigenetic dysregulation and altered maternal metabolic health are associated with
metabolic complications in offspring. Whether estrogen receptors (ERs) or estrogen-like receptors
play a role in mediating the BPA-induced metabolic defects remains to be determined; links
between estrogen signaling and insulin biosynthesis and release, however, have been reported
(Alonso-Magdalena et al. 2006).

3.7. Contributions
This chapter contains figures from Susiarjo et al. published in 2015 in Endocrinology. Dr.
Martha Susiarjo spearheaded the project, designing, planning, and executing/supervising
experiments in this study. I was responsible for helping to generate F2 embryos and adults for the
multigenerational assessments. I performed the allelic expression studies at select imprinted
genes in F2 hybrid midgestation offspring. This data was not shown in the study because no loss
of imprinting was detected. I also worked alongside Dr. Martha Susiarjo during the coordination of
physiological assessment with the Mouse Phenotyping, Physiology, and Metabolism Core
(University of Pennsylvania, directed by Dr. Rexford Ahima at the time). Finally, I contributed to
the writing of the original manuscript.
Dr. Amita Bansal (Rebecca Simmons Laboratory, University of Pennsylvania and
Children’s Hospital of Philadelphia) generated an independent BPA exposure cohort in an
additional on-campus animal facility to validate the robustness of the observed metabolic
phenotypes. Members of the Mouse Phenotyping, Physiology, and Metabolism Core, including
Research Specialist Dr. Xiaoyan Yin and Mr. Charles Cudjo Addo-Yobo helped with DEXA scans
and GTTs. Dr. Changhong Li (CHOP) was instrumental in generating the islet perifusion data.
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Figure 3.1. F1 adult growth curve and body composition assessments. F1 adult male and
female growth curves and dual energy x-ray absorptiometry (DEXA) scan results. (A) Growth
curves of F1 male mice. Lower dose F1 male mice exhibit reduced birth weight followed by catch
up growth. No significant body weight differences in control or BPA-exposed F1 male offspring
from postnatal day (PND) 28-PND98. (B) DEXA scan reveals significantly increased body fat
percentage in lower and upper dose BPA-exposed F1 male mice. (C) Areal bone mineral density
and (D) bone mineral content, determined by DEXA, are significantly reduced in upper dose F1
male offspring while females are not affected. C: Control, L: Lower dose BPA, U: Upper dose
BPA.
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Figure 3.2. F1 adult male glucose tolerance test (GTT) and islet perifusion studies. (A)
Glucose area under the curve was elevated in BPA-treated male mice by GTT, indicative of
glucose intolerance. (B) Basal insulin release was increased in upper dose BPA F1 male mice.
(C) Glucose (G)-stimulated insulin release was significantly impaired in F1 lower dose males.
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Figure 3.3. F2 whole embryo gene expression and DNA methylation assessments. Fetal F2
Igf2 gene expression and DNA methylation. (A) Total mRNA expression of Igf2 was increased in
upper dose midgestation whole embryo. (B) Upper dose BPA-exposed F2 whole embryo
displayed increased DNA methylation at CpG site 2 of Igf2 differentially methylated region (DMR)
1; DNA methylation determined by bisulfite conversion and pyrosequencing.
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Figure 3.4. F2 adult physiological testing. (A) Body fat percentage, determined by DEXA. (B)
Glucose area under the curve, assessed by GTT. F2 upper dose males display increased body
fat and glucose intolerance. (C) Basal insulin release and (D) glucose-stimulated insulin release
in ex vivo islet perifusion studies. Lower dose BPA F2 generation males continue to exhibit
impaired glucose-stimulated insulin secretion.
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Figure 3.5. Genetically engineered mouse model of Igf2 overexpression phenocopies
metabolic phenotype in BPA-exposed offspring. (A) Diagram of wildtype (WT, +/+, top) and
mutant (Δ3.8/+, bottom) H19/Igf2 loci. In the WT condition, CTCF binds to the unmethylated
maternal imprinting control region (ICR), preventing shared downstream enhancers (E) from
interacting with, and activating, Igf2 expression. In the Δ3.8 mouse model, a 3.8 kb deletion that
includes the H19/Igf2 ICR, results in no CTCF binding. When inherited maternally, offspring have
no CTCF bound to the H19/Igf2 ICR, resulting in biallelic Igf2 expression and transcriptionally
silenced H19. (B) F1 H19Δ3.8/+ adult male that overexpress Igf2 exhibit impaired glucose tolerance
similar to the BPA-exposed offspring.
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Figure 3.6. Gestational glucose tolerance test. Gestational glucose intolerance may contribute
to the phenotype in F1, but not F2, offspring. Glucose tolerance was assessed in pregnant (A) F0
and (B) F1 females on gestation day 16.5-17.5. F0 lower and upper dose dams demonstrated
significantly elevated glucose areas under the curve, while F1 upper dose dams exhibited
comparable glucose tolerance to controls.
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CHAPTER 4.
BPA AND BONE
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CHAPTER 4 BPA AND BONE
4.1 Background and study rationale
While BPA-induced phenotypes have been assessed in a variety of endocrine-sensitive
tissues (Xin et al. 2015), the skeletal system has been relatively overlooked. Importantly, much of
the variation in adult bone mass is established by young adulthood, suggesting bone function in
later life greatly depends on proper skeletal development in early life (Wang et al. 2009). Bone
health in offspring is known to be modifiable by maternal nutrition and lifestyle (Holroyd et al.
2012; Migliaccio et al. 1996), but the effects of maternal EDC exposure on offspring skeletal
development are not well-studied.
Human case studies and genetic mouse models have demonstrated critical roles for sex
steroid signaling in bone remodeling (Cardelli and Aubin 2014; Delhon et al. 2009; Ford et al.
2011; Mårtensson et al. 2009; Vanderschueren et al. 2014). Single and double ER knockout (KO)
studies have suggested that ERα plays the predominant role in maintaining bone mass in both
male and female mice (Vanderschueren et al. 2014). While deletion of ERα reduced cortical bone
thickness and cortical bone mineral density in both male and female mice, loss of ERβ alone had
no significant effects on bone mass, and ERα/β null mice displayed bone phenotypes comparable
to ERα single KO mice (Sims et al. 2002). In addition to the classical receptors, the non-classical
GPER and two members of the ERR family, ERRα and ERRγ, have also been implicated in bone
growth (Cardelli and Aubin 2014; Delhon et al. 2009; Ford et al. 2011; Mårtensson et al. 2009).
While not the focus of this article, androgens, independent of aromatization into estrogen, bind to
their cognate receptor and stimulate additional bone mass acquisition in male mice
(Vanderschueren et al. 2014). Given the presence of multiple sex steroid receptors in the skeletal
system, it is likely that EDC exposure could interfere with skeletal health.
Here, we discuss the evidence for EDC-induced changes in skeletal strength, with an
emphasis on BPA. We present previously unpublished data from our own BPA exposure studies
demonstrating dose-, sex-, and generation-specific differences in skeletal morphology and
mechanical function following gestational and lactational exposure to BPA. Moreover, we
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describe, for the first time, multigenerational assessments of skeletal strength following BPA
exposure transmitted through the maternal germline. In an extended discussion, we compare
BPA-induced skeletal alterations with those of other well-established exogenous estrogens and
discuss potential molecular mechanisms contributing to the observed phenotypes, with a focus on
epigenetic dysregulation.

4.2. Developmental BPA exposure is associated with sex-specific alterations in
adult femur morphology
In our exposure paradigm, C57BL/6J virgin female mice (designated the F0 generation)
were chronically exposed to BPA through the diet at one of two doses: 10 μg or 10 mg per kg
bw/d, referred to as lower and upper dose BPA, respectively. Serum assessments demonstrated
that circulating BPA levels in F0 dams were comparable to those reported in humans
(Schönfelder et al. 2002a; Susiarjo et al. 2013). Exposures began two weeks prior to mating and
continued through gestation and lactation, after which F1 offspring were weaned onto a control
diet at postnatal day (PND) 21. F0 and F1 generation females were mated to unexposed males to
produce F1 and F2 generations, respectively.
To understand the functional implications of developmental BPA exposure on adult
skeletal strength, we focused our analyses on the mid-diaphysis of the femur, a region consisting
primarily of cortical bone. Because cortical bone is most often used to predict bone strength,
assessments in this area would directly correspond to the region analyzed in four-point bending
tests for mechanical strength. We first examined femoral structure to identify biomechanical
changes that may contribute to alterations in bone strength (Figure 4.1, Table 4.1). Femur length
was comparable across groups and sex, suggesting longitudinal growth, an endochondral
process, was not impaired by BPA exposure. On the other hand, lateral growth, as measured by
cross-sectional areas of the femur, appeared to be affected in a sex- and dose-specific manner
(Table 4.1). Total cross-sectional area, which depends on osteoblast function, was significantly
reduced in upper dose males. Robustness, the ratio of total cross-sectional area to femur length
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and a parameter predictive of bone strength (Bhola et al. 2011), was reduced in upper dose BPA
male mice (Table 4.1). The moderately reduced cortical area of BPA-exposed males was
appropriately adapted for the narrower structure (Table 4.1). Total cross-sectional, robustness,
and cortical area were unaffected in F1 female mice. However, upper dose BPA-exposed F1
female mice displayed reduced tissue mineral density while males were unaffected (Table 1).
Thus, developmental BPA exposure is associated with dose- and sex-specific alterations in
femoral morphological parameters that could influence bone strength.

4.3. Early life exposure to BPA is associated with altered femur strength in males
We next asked whether these morphological changes were sufficient in magnitude to
elicit changes in mechanical function. Individuals with narrow bones have historically shown a
higher risk of fracturing throughout life (Beck et al. 1996; Szulc et al. 2006). Because long bone
stiffness and strength are proportional to the fourth and third powers of external bone size,
respectively, we hypothesized that the small reductions in external bone size in BPA-exposed
males would affect whole bone strength. In females, the reduced tissue mineral density could
also be predictive of enhanced susceptibility to fracture (Small 2005). Using four-point bending to
assess the maximum load (i.e. strength) femurs could withstand prior to fracture, only BPAexposed F1 males demonstrated reduced whole bone stiffness and strength compared to
controls (Figure 4.2, Table 4.1). Given the nonlinear relationship between outer bone size and
whole bone strength, it is not surprising that lower dose BPA-exposed F1 males also exhibited
impaired whole bone mechanical function. F1 female bone stiffness and strength, on the other
hand, were not significantly affected by BPA exposure.
BPA-induced multi- and transgenerational effects in non-skeletal endpoints have been
reported by our lab and others (Xin et al. 2015). Therefore, we next asked whether the BPAinduced skeletal changes in the F1 generation could also be transmitted to the subsequent (F2)
generation. The reduced femoral stiffness, strength, and robustness in BPA-exposed F1 males
were not observed in F2 generation males (Figure 4.2, Table 4.1). Conversely, F2 lower dose
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BPA males showed increases in whole bone strength relative to controls. Unlike the F1
generation, the altered strength in the F2 lower dose males cannot be explained by any of the
assessed femoral cross-sectional parameters (Table 4.1). The functional changes in the F2 lower
dose males could be an adaptive response. Alternatively, as previously mentioned, the distinct
molecular pathways susceptible to environmental perturbations at each developmental stage
could drive different phenotypic outcomes. The F2 females showed no significant difference in
any assessed morphological parameter compared to F2 female controls (Table 4.1).
In summary, developmental exposure to BPA in our exposure paradigm resulted in sex-,
dose-, and generation-specific changes in morphology and function. Although some
morphological changes were identified in F1 and F2 generation females, these alterations were
not sufficient to generate a change in bone strength. The bone findings are consistent with our
previous studies that demonstrate male-specific effects associated with developmental BPA
exposure (Bansal et al. 2017; Susiarjo et al. 2015). We acknowledge, however, that the small
sample and litter size in the lower dose F1 and F2 generation females in this study increases the
possibility of a false negative finding. Most striking are the functional changes in BPA-exposed
males, with deficits in F1 generation femur strength being directly associated with a narrower
bone structure. Given that outer bone surface expansion of the mid-diaphysis largely depends on
osteoblastic activity and to a lesser extent osteoclastic activity, the data suggest that BPA in our
exposure model exerts effects in F1 generation males by suppressing osteoblast activity on the
periosteal surface (Figure 1). Future investigations assessing osteoblast number and function will
provide greater insight into the sex-specific mechanism of BPA-induced skeletal pathophysiology.

4.4. Discussion
The limited studies assessing skeletal health following developmental exposure to BPA
and other exogenous estrogens have reported variable outcomes (Table 4.2). Due to the
heterogeneity in experimental design among the published reports, it is difficult to discern the
source(s) of discrepancy. Differences such as rodent strain, dose, route of administration,
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duration of exposure, age of assessment, and bone type could all contribute to variable findings
in the literature (Table 2). Regardless, these reports provide evidence for skeletal susceptibility to
exogenous estrogenic EDCs.
Three other studies have assessed changes in femoral morphology and function
following early life exposure to BPA, each with its own unique combination of morphological
changes (Lejonklou et al. 2015; Lind et al. 2017; Pelch et al. 2012). However, unlike our study,
none of the previously reported morphological changes were large enough to produce effects on
bone strength (Table 4.2). Compared to the other studies, our doses and the age of assessment
are roughly equivalent. Unique to our study, though, is the route of BPA administration and
duration of exposure. Our chronic exposure included the entire gestational and lactational
periods. Therefore, our exposure window could be targeting a critical period in early development
in which BPA exposure exerts its effects on bone strength that is not captured in the other
studies. While our study evaluated BPA-induced multigenerational skeletal effects transmitted
through the maternal germline, one other study assessed multigenerational outcomes occurring
through the paternal germline (Auxietre et al. 2014). When male mice continuously exposed to
BPA beginning at the time of conception were mated to unexposed females, their offspring did
not exhibit any changes in bone morphology relative to controls, suggesting the skeletal effects of
BPA exposure are limited to the F1 generation (Auxietre et al. 2014). It is not known, however, if
the affected female could have transmitted skeletal health aberrations to the F2 generation.
While BPA is structurally similar to estrogen, its pleiotropic effects suggest that its
mechanisms of action may not be limited to pathways mediated by estrogen (Xin et al. 2015). Not
surprisingly, when compared to other established estrogenic chemicals, notably diethylstilbestrol
(DES), estradiol benzoate (EB), and ethinyl estradiol (EE), the effects of BPA demonstrate some
parallel, but also unique, changes (Table 4.2).
DES, a synthetic estrogen with high affinity for ER, was prescribed to pregnant women in
the United States from the 1940s to the 1970s in an attempt to reduce the risk of miscarriage
(Hilakivi-Clarke 2014). Both DES-exposed children and grandchildren have been reported to be
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at increased risk for several reproductive health-related outcomes (Schmidt 2013), providing
evidence for EDC-induced multigenerational effects in humans (Xin et al. 2015). Unfortunately,
the skeletal health consequences of DES exposure are not well-defined in humans. In rodent
models, DES exposure-induced skeletal alterations have generally been sex-specific (Table 4.2).
When affected, bone mass in males tends to be reduced (Fukazawa et al. 1996; Kaludjerovic and
Ward 2008), similar to what we observed in our BPA exposure model. However, DES-exposed
females tend to display increases in bone mass (Kaludjerovic and Ward 2008; Migliaccio et al.
1992, 1996), while BPA-exposed females in our study were minimally affected by the exposure. It
is worth noting that the route of DES administration in the majority of these studies occurred
through injection, which may augment the effect of DES (Table 4.2). Consistent with our BPA
exposure model, the morphological changes associated with DES exposure did not always
predict functional changes (Table 4.2), again emphasizing the need to validate physiological
changes in the presence of EDC-induced morphological differences.
EE and EB are synthetic estrogens most commonly used in human oral contraceptive
pills and in promoting livestock weight gain, respectively (Cavalieri et al. 2004; Rumsey et al.
1992; Sitruk-Ware 2016; Strufaldi et al. 2010). Following developmental EE exposure, Pelch and
colleagues observed a reduction in femoral strength in adult female mice that could not be
explained by altered morphology (Pelch et al. 2012). The authors speculated that differences in
mineral composition of EE-exposed bones may have contributed to the compromised bone
strength. In a second study, continuous exposure to EE from conception throughout adult life sexspecifically decreased vertebral bone mass in female mice, while femoral and tibial mass were
not affected (Hotchkiss et al. 2008). Unfortunately, no mechanical testing was performed to
determine the functional consequences associated with these morphological changes. Of all
exogenous estrogen studies, the effects of BPA in our study are most similar to those following
an acute administration of EB on PND1 (Table 4.2), which resulted in male-specific reductions in
bone mass and strength, while females were unaffected (Connelly et al. 2015). A second study
using a greater dose of EB coupled with a longer exposure again resulted in reduced bone mass
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in males but did not translate to significant changes in bone function (Fagnant et al. 2014). In
addition to technical variability in study design, the hallmark non-monotonic nature of EDCs
supports the possibility of distinct effects at different doses (Bansal et al. 2017; Susiarjo et al.
2015; Xin et al. 2015).
While most of the studies published thus far have reported small changes in skeletal
morphology that do not necessarily translate into functional differences, these studies have also
been limited in the type of bone (i.e. femur) assessed. Femur, tibia, and vertebrae are composed
of different proportions of cortical and cancellous bone, which have been shown to be
differentially affected in sex steroid receptor knockout mice (Vanderschueren et al. 2014).
Cancellous bone, also known as spongy or trabecular bone, forms a web-like network within the
marrow cavity and serves as the site of active bone remodeling; it is found in greater proportions
at the ends of joints (Figure 4.1) and in vertebrae (Hotchkiss et al. 2008; Regard et al. 2012). In
studies that have assessed bone mass and strength in multiple bone types (Table 4.2), vertebrae
are often the most susceptible to exposure (Fagnant et al. 2014; Hotchkiss et al. 2008;
Kaludjerovic and Ward 2008; Migliaccio et al. 1996; Rowas et al. 2012). Future BPA studies,
therefore, would benefit from more comprehensive investigations of cortical and cancellous bone
health in male and female offspring. The careful coordination of the morphologies and material
properties of these bone components is crucial for bone functional homeostasis. Furthermore,
molecular investigations are required to determine the underlying mechanistic changes driving
the associated phenotypic consequences.

4.5. Extended discussion: A role for epigenetic regulation in skeletal dysfunction?
Tremendous progress has been made in understanding the molecular mechanisms
responsible for bone metabolism, with epigenetic mechanisms emerging as key regulators of
skeletal homeostasis. This section will discuss the role of two major epigenetic regulatory
mechanisms in bone formation: DNA methylation and histone post-translational modifications
(PTMs). Of note is the extensive crosstalk that occurs between epigenetic modifications and
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signaling pathways involved in bone formation (Bradley et al. 2011; Husain and Jeffries 2017; Xin
et al. 2015), adding further complexity to the identification of the driving factor(s) responsible for
EDC-induced skeletal phenotypes. While in vitro studies in isolated cell populations provide a
useful starting point for identifying mechanisms of EDC action on bone (Regard et al. 2012;
Westendorf 2007), the extensive paracrine signaling that occurs between bone cell types requires
in vivo validation to demonstrate functional significance. In addition, because tissue-specific
transcriptional coregulators could be disrupted by estrogenic EDCs as opposed to epigenetic
regulators or ERs themselves, care must be taken in generalizing EDC-induced effects across
tissues.

4.5.1. DNA methylation
DNA methylation involves the covalent addition of a methyl group to a cytosine base,
most commonly in a CpG dinucleotide context in mammals (Xin et al. 2015). Depending on the
genomic region of the mark, DNA methylation can be associated with either gene repression or
serve as a marker of an actively transcribed region (Xin et al. 2015). DNA methyltransferases
(DNMTs) add the methyl group to the cytosine; loss of DNA methylation can occur in a passive,
replication-dependent manner or through an active process of methylcytosine oxidation by the
ten eleven translocation (TET) family of enzymes (Kohli and Zhang 2013). If EDCs alter the
activity of DNA methylation-associated enzymes, the consequences could be widespread. Global
changes in DNA methylation can influence genomic stability as well as critical processes such as
cell fate determination (Schübeler 2015).
Multiple genes and processes have been reported to be regulated by DNA methylation.
With the proper activation of key lineage-determining factors, mesenchymal stem cells (MSCs)
can differentiate into various cell types, including the bone-forming osteoblasts. Runt-related
transcription factor 2 (RUNX2) is critical to the regulation of early osteoblast commitment
(Vanderschueren et al. 2014). In primary human bone marrow-derived stromal cells, DNA
methylation at the RUNX2 promoter was inversely correlated with its expression (Westendorf
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2007). Target genes of RUNX2, including osteoblast differentiation markers osteocalcin,
osteopontin, and osterix have also been reported to undergo changes in DNA methylation during
differentiation (de Andrés et al. 2013; Gordon et al. 2015; Sepulveda et al. 2017).
Sclerostin (Sost/SOST), a paracrine factor expressed by osteocytes, or terminally
differentiated osteoblasts, suppresses Wnt/β-catenin signaling in osteoblasts and subsequent
bone formation (Regard et al. 2012). Increased DNA methylation at the SOST promoter is
associated with reduced expression in primary human cancellous bone (Husain and Jeffries
2017), and both DNA methylation and expression have been reported to strongly correlate with
fracture risk in humans (Reppe et al. 2015). Essential to osteoclastogenesis, the catabolic
process in bone metabolism, is the activation of the receptor activator of nuclear factor kappa-B
(RANK)/RANK ligand (RANKL) pathway. Activation of this pathway and subsequent osteoclast
formation can be disrupted by a decoy ligand, osteoprotegerin (OPG) (Khalid and Krum 2016).
RANKL and OPG are both paracrine factors expressed by osteoblasts, and increased DNA
methylation in their promoters is associated with reduced expression in rodent and in human
osteoblast cell lines, respectively (Delgado-Calle et al. 2012; Husain and Jeffries 2017).
Reports on estrogenic EDC-induced changes in bone DNA methylation in vivo are
sparse. Nevertheless, estrogen and BPA have been reported to increase OPG expression in
human osteoblasts and decrease Rank expression in murine pre-osteoclast cells in vitro (Hwang
et al. 2013; Khalid and Krum 2016). By reducing the availability of the RANK ligand or its
receptor, both estrogen and BPA induce a net loss in RANK/RANKL signaling, ultimately
impairing osteoclast activity. DES administration also impairs osteoclast activity in ovariectomized
mice by simultaneously inducing OPG and suppressing RANKL expression, thus restoring
ovariectomy-induced bone loss (Liu et al. 2012). It is not known whether these changes in
expression are due to epigenetic dysregulation and warrant further investigation.
The necessity of intact classical and/or non-classical ERs to mediate these EDC-induced
skeletal changes remains unclear. Estrogen-bound ERα and/or ERRα are both capable of
stimulating and repressing RUNX2 activity in human and rodent osteoblasts in a developmental
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stage-specific manner (Carnesecchi and Vanacker 2016; Khalid et al. 2008; McCarthy et al.
2003), suggesting EDCs could similarly interfere with these processes. Moreover, whether ERmediated signaling can influence DNA methylation in bone is not known. Work in non-skeletal
tissues suggest that the expression of DNMTs and ERs is mutually regulated in humans and
rodents, although directionality may vary given the tissue type, available coregulators, and the
transformed state of the cells (Cui et al. 2009; Issa et al. 1996; Ratnu et al. 2017; Yamagata et al.
2009). Developmental BPA exposure has been reported to increase DNMT expression, increase
DNA methylation in the promoter of the ERα-encoding gene, Esr1, and reduce Esr1 gene
transcription in a sex- and brain region-specific manner in BALB/c mice (Kundakovic et al. 2013).
Whether these relationships translate to the skeletal system remains to be explored.

4.5.2. Histone post-translational modifications
The most widely researched epigenetic regulators in the context of bone are enzymes
that add or remove histone post-translational modifications (PTMs) (Gordon et al. 2015). Histone
PTMs, including methylation and acetylation, are epigenetic marks capable of influencing gene
expression through alterations in chromatin accessibility as well as the recruitment or prevention
of transcription factor binding that is sensitive to the modification (Kouzarides 2007). As a family
of epigenetic regulators, histone modifying enzymes exhibit broad activity across multiple cell
types, and mouse genetic deletion studies have demonstrated a role for many of these enzymes
in skeletal development and homeostasis (Bradley et al. 2011; Gordon et al. 2015; Westendorf
2007).
In MSCs, trimethylation of lysine residue 27 of histone H3 (H3K27me3) plays a critical
role in lineage specification (Gordon et al. 2015). The histone methyltransferase responsible for
this mark, Enhancer of Zeste 2 (EZH2), is a subunit of the Polycomb Repressive Complex 2
(PRC2) (Gordon et al. 2015). A mesenchyme-specific deletion of Ezh2 resulted in heterozygous
and homozygous offspring displaying thinner cortical bone and compromised bone function
(Hemming et al. 2017). In addition to deleterious effects in the skeleton, Ezh2 null mice displayed

68

significant increases in marrow adipose, providing further evidence for EZH2 as a critical switch in
MSC fate commitment (Hemming et al. 2017). Conversely, pharmacological inhibition of EZH2 in
skeletally mature, ovariectomized mice alleviated estrogen-depleted bone loss (Dudakovic et al.
2016), suggesting timing of disrupted EZH2 function as well as circulating hormone levels may
influence the directionality of responses.
Among the histone modifying enzymes, histone deacetylases (HDACs) have received the
most attention for their role in bone development. HDACs are a large family of enzymes
responsible for the removal of acetyl groups from histone tails and other proteins (Kouzarides
2007). As a result, enzymes that recognize the acetyl mark can no longer bind, the interaction
strength between the negatively charged DNA and positively charged histones increases, and
transcription is reduced (Kouzarides 2007). Frequently reported HDACs to be altered following
estrogen and/or EDC exposure in non-skeletal tissues (Fortress et al. 2014; Jefferson et al. 2013;
Kumar and Thakur 2017b) are the class I HDACs (HDAC1, HDAC2, and HDAC3) and will be
discussed here. While many other HDACs have also been reported to regulate bone
development (Bradley et al. 2011; Gordon et al. 2015; Westendorf 2007), their potential
susceptibility to EDCs is unknown. Of note, HDAC-mediated regulation of osteogenesis has been
suggested to occur via both deacetylation-dependent (Lee et al. 2006) and deacetylationindependent (Jensen et al. 2008) mechanisms.
Because class I HDACs are widely expressed, constitutive loss of these enzymes results
in embryonic (HDAC1 and HDAC3) or perinatal (HDAC2) lethality, underscoring the necessity for
tissue-specific gene deletion models to study their precise roles in bone development (Bradley et
al. 2011). In vitro evidence suggests that HDAC1 regulates osteoblast differentiation via physical
interactions with RUNX2, subsequently decreasing RUNX2 target gene transcription and
osteogenesis (Lee et al. 2006). Whether HDAC1 is physically obstructing RUNX2 binding to DNA
or its deacetylase activity is restricting chromatin accessibility around RUNX2 target genes
remains to be determined. In dental pulp stem cells, HDAC2 depletion resulted in reduced mRNA
expression of osteocalcin, a late-stage osteoblast differentiation marker, suggesting a role for
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HDAC2 in osteogenesis (Paino et al. 2014). In vivo, males and females with a conditional deletion
of Hdac3 in pre-osteoblastic cells demonstrated reduced trabecular and cortical bone density and
thinner cortical bone, which were associated with reduced osteoblast number (Razidlo et al.
2010). Concurrently, HDAC3 depletion increased marrow fat, suggesting HDAC3 also serves as
a MSC lineage commitment switch (Razidlo et al. 2010).
Given the lack of data demonstrating estrogen-mediated modulation of EZH2 or the class
I HDACs in the context of bone, we discuss reports in non-skeletal tissues as a proof-of-concept.
The Ezh2 promoter contains multiple functional estrogen response elements, and its expression
in the mammary gland of ovariectomized rats is increased upon estradiol administration (Bhan et
al. 2014). To our knowledge, no studies have examined the relationship between classical or nonclassical ERs and class I HDACs in non-transformed systems. However, in cancer cell models of
the breast, another well-established estrogen-sensitive tissue, it has been suggested that HDAC1
negatively regulates ERα activity by binding to multiple functional domains or by reducing
transcription factor accessibility to the Esr1 gene promoter (Hervouet et al. 2013). Whether
estrogenic EDCs target histone modifying enzymes in bone and/or require intact ERs to mediate
their effects requires further investigation.
Much work is needed to determine the role of epigenetics in EDC-induced skeletal
dysfunction. Based on the available literature, it is clear that epigenetic machinery is susceptible
to EDC exposure in non-skeletal tissue types (Kundakovic et al. 2013; Xin et al. 2015). Further,
other studies have demonstrated a critical role for epigenetic regulation in proper skeletal
development and maintenance (Bradley et al. 2011; Gordon et al. 2015; Westendorf 2007). No
study to date, however, has directly assessed epigenetic involvement in the skeletal system
following developmental EDC exposure. Future investigations that address this research question
will provide critical insights into the mechanism(s) of EDC action on bone biology. In addition,
whether the classical and/or nonclassical receptors act up- or downstream of the epigenetic
modifications, if at all, in the context of bone require further study (Figure 3). Given the paucity of
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information on EDC-induced molecular changes in bone, especially those related to epigenetic
dysregulation, countless opportunities for novel discoveries exist.

4.5.3. Final considerations and conclusion
While EDC-induced skeletal effects could be disrupting pathways in bone cells directly, it
is also possible that the effects on skeletal health are secondary to other physiological changes.
For example, EDCs that target MSCs and promote adipocyte differentiation at the expense of
osteoblast formation would indirectly compromise bone health. Phthalates and tributyltin, two
non-estrogenic EDCs, have been best studied for their ability to activate the epigenetically
modifiable master regulator of adipogenesis, peroxisome proliferator activated receptor γ
(PPARγ), and divert MSCs toward an adipogenic fate (Bateman et al. 2017). Additionally,
adverse metabolic health in both the gestating mother and offspring have been associated with
poor bone health in animal models and humans (Gower and Casazza 2013; Hamrick et al. 2009;
Kovacs and Kronenberg 1997; Namgung and Tsang 2000). In our BPA exposure model, we
previously reported BPA-induced gestational diabetes in F0 dams and adverse metabolic health
outcomes in F1 and F2 offspring (Susiarjo et al. 2015), suggesting BPA-induced skeletal system
dysfunction could be a secondary effect of perturbed metabolic health. Assessing both metabolic
and skeletal postnatal outcomes following early life EDC exposure may provide clues regarding
the target cell(s) of EDC action: the co-occurrence of metabolic and skeletal alterations would
warrant further investigation in progenitor cell populations while physiological changes in only one
system would point toward effects in more differentiated cell types.
A greater understanding of the epigenetic reprogramming events that occur during preimplantation embryo and fetal germ cell development will also provide greater mechanistic insight
into the transmission of phenotypes to the F1 and F2 generation offspring, respectively. While the
F1 zygote undergoes a global wave of epigenetic reprogramming to establish an initial pluripotent
state, its germ cells undergo a second wave of reprogramming in order to reset marks in the
gametes according to the sex of the developing embryo (Saitou et al. 2012). Of note, the global
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loss of DNA methylation in fetal germ cells, known as primordial germ cells (PGCs), is more
extensive than the reprogramming following fertilization, including the erasure of previously
protected imprints and some repetitive transposable elements (Saitou et al. 2012). Additionally,
the identification of epigenetic modification enzymes that function exclusively during one wave of
reprogramming (Saitou and Yamaji 2012) suggests unique epigenetic reprogramming
mechanisms exist within each generation that may yield differential susceptibility to environmental
triggers. The failure to properly erase, establish, and/or maintain these epigenetic marks during
either stage of reprogramming could, therefore, contribute to distinct maladaptive, or possibly
adaptive, responses to later life environment.
Although not discussed in great detail here, the molecular basis for frequently reported
sex-specific responses to EDC exposure also requires further investigation. In the case of malespecific phenotypes such as our BPA exposure model, it is possible that systemic androgens are
being affected. In addition to directly measuring circulating sex steroids in adult rodents, future
assessments of skeletal phenotypes prior to puberty would provide further indication for the
requirement of circulating hormones to elicit sex-specific skeletal effects. On the other hand,
sexually dimorphic development during gestation may allow for sex-specific effects independent
of pubertal and adult sex steroid actions. Placentas associated with male fetuses exhibit distinct
adaptation strategies in the face of environmental perturbations relative to female-associated
placentas (Clifton 2010). Female fetuses are also protected from endogenous, and possibly
exogenous, estrogens in the maternal milieu via alpha-fetoprotein binding, subsequently reducing
estrogen-mediated actions on target cells (McHenry et al. 2014). Furthermore, sex-specific DNA
methylation profiles are already apparent at birth (Ratnu et al. 2017), suggesting distinct fetal
epigenetic programming in males and females that could be differentially impacted by EDC
exposure. Finally, several genes encoding histone modifying enzymes are located on sex
chromosomes, providing other potential targets for sex-biased susceptibility to EDCs (Carrel and
Brown 2017).
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In summary, there is sufficient evidence in the literature, and results described here, to
suggest developmental exposure to estrogenic EDCs can disrupt skeletal strength, but the
underlying mechanisms driving these changes remain unclear. Additionally, the expression
and/or activity of a variety of epigenetic enzymes, classical ERs, and non-classical ERs are
susceptible to estrogenic EDCs in vitro and in non-skeletal tissues in vivo. However, the extent to
which these effects translate to the skeletal system and influence skeletal function remains to be
determined (Figure 4.3). Future coordinated efforts across research labs to systematically
evaluate the impact of various exposure routes, genetic background, and outcome variables will
aid in defining the molecular and physiological effects of BPA and other EDCs on skeletal
strength. Ultimately, a more comprehensive analysis of the effects of EDC exposure on whole
organism physiology may help guide future public policy and regulation of these chemicals and
others.

4.6. Contributions
This chapter includes direct quotes and figures from Xin et al. (In Press) submitted to
Environmental Epigenetics (Xin et al.). Dr. Marisa S. Bartolomei (MSB) and Dr. Martha Susiarjo
(MS) established the initial collaboration with Dr. Karl J. Jepsen (KJJ, University of Michigan) to
investigate skeletal effects associated with developmental BPA exposure. Mouse carcasses and
isolated femurs were sent to Ms. Lauren M. Smith (LMS) of the Jepsen laboratory, with the help
of Mr. Chris Krapp. LMS, MS, and FX performed the experiments and acquired the data. LMS
and FX analyzed the data. MS, FX, LMS contributed reagents/materials/analysis tools. FX and
LMS wrote the paper.
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Table 4.1. Skeletal morphology and physiology. Percent difference in bone traits by exposure
group (lower dose or upper dose) compared to the sex matched control group.

F1 Males
Traits
N
BW (g)
Femur Le
(mm)
Tt.Ar (mm2)
Robustness
(mm)
Ct.Ar (mm2)
Ma.Ar (mm2)
TMD
(mgHA/cc)
Stiffness
(N/mm)
ML (N)
PYD (mm)
Work (Nmm)

F1 Females

F2 Males

F2 Females

Lower
5
3.5%

Upper
15
-0.4%

Lower
4
9.8%

Upper
12
-6.7%

Lower
18
-0.7%

Upper
21
1.4%

Lower
4
9.1%

Upper
12
0.4%

-1.7%

-0.3%

0.8%

-1.6%

0.3%

-1.2%

-0.3%

0.0%

-9.0%

-7.1%

2.2%

0.3%

1.7%

-2.6%

-3.5%

-4.7%

-7.3%

-6.9%

2.2%

1.4%

1.4%

-1.3%

-1.6%

-4.6%

-3.0%
-8.7%

-2.2%
-6.3%

2.2%
0.5%

-3.0%
1.8%

2.3%
0.1%

-0.1%
-3.2%

1.7%
-6.4%

-6.8%
-0.2%

-0.8%

0.7%

-0.2%

-1.9%

0.4%

0.6%

-0.9%

2.3%

-19.6%

-15.9%

9.8%

-7.6%

12.8%

13.7%

9.2%

-18.2%

-13.0%
-0.6%
-10.6%

-17.0%
12.0%
-7.3%

9.1%
-12.0%
4.2%

1.7%
40.2%
36.6%

14.0%
-5.3%
13.4%

6.4%
16.8%
21.9%

9.0%
72.0%
45.0%

-13.4%
-26.9%
-32.1%

BW and Femur Le are adjusted by age (days). All other traits have been adjusted for BW and age
except Ct.Ar and TMD that have been adjusted for BW, age, and robustness. Bold font and
shaded cell indicates significant differences (p<0.05) relative to the sex matched controls (F1
male: N=13; F1 female: N=8, F2 male: N=18, F2 female: N=9). Values were calculated from
means determined with general linear model ANOVAs.

Abbreviations: BW: body weight; Ct.Ar: cortical area; Femur Le: femur length; HA: hydroxyapatite;
Ma.Ar: marrow area, ML: maximum load (in Newtons); PYD: post-yield displacement; TMD:
tissue mineral density; Tt.Ar: total cross-sectional area; Work: work-to-fracture

74

Table 4.2. Skeletal consequences following early life exposure to exogenous estrogen or estrogenic EDCs
Estrogen
Rodent
Dose(s);
Exposure
Age of
Bone
Sex
or EDC
strain
Route of administration
window
assessment
BPA
C57BL/6J
10 μg/kg/d;
E11-PND12
13-23 wks
Femur
M
Osmotic pump
F

Bone
mass
↔
↔

Bone
strength
↔
↔

Ref

Ma
F
Ma
F

↓
↔
↑/↔
↔

↔
↔
↔
↔

(Lejonklou et al.
2015)

(Pelch et al.
2012)

BPA

Fischer
344

0.5 or 50 μg/kg bw/d;
Drinking water

E3.5-PND22

5 wks

Femur

BPA

Wistar

E7-PND22

12 wks

Femur

BPA

Wistar
Han

0.025, 0.250, 5, or 50
mg/kg bw/d;
Gavage
5 μg/kg/d;
Gavage

E0-PND110
(Continuous)

PND110

Vertebra

M
F

↔
↔

ND
ND

(Auxietre et al.
2014)

DES

C57BL/6J

E11-E14

4 mos

Femur

M
F

↔
↔

ND
ND

(Rowas et al.
2012)

Vertebra

M

↔

ND

Fa
M
F
M
F
M
F
M
F
M
F

↓/↑
ND
↔
ND
↑
ND
↑
ND
↑
↓
↑

ND
ND
ND
ND
ND
ND
ND
ND
ND
↔
↑

M
F

↓
↑

↓
↑

DES

DES

CD-1

CD-1

0.1, 1, 10 μg/kg/d;
Injection

0.1, 2.5, 5, 10, 50, or 100
μg/kg bw/d;
Injection

E9-E16

2 μg/d;
Injection

PND1-PND5

7-9 mos

Femur
Vertebra

12-14 mos

Femur
Vertebra

DES

CD-1

2 mg/kg bw/d;
Injection

PND1-PND5

4 mos

Femura
Vertebra
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(Lind et al.
2017)

(Migliaccio et al.
1996)

(Migliaccio et al.
1992)

(Kaludjerovic
and Ward 2008)

DES

C57BL/Tw

3 μg/d;
Injection

PND1-PND5

15 mos

Femur

M

↓

ND

F

ND

ND

Pelvis

M

↓

ND

F
M
F

ND
↔
↔

ND
↓
↔

(Pelch et al.
2012)

(Fukazawa et al.
1996)

DES

C57BL/6J

0.1 μg/kg/d;
Osmotic pump

E11-PND12

13-23 wks

Femur

EE

C57BL/6J

0.01, 0.1, or 1 μg/kg/d;
Osmotic pump

E11-PND12

10 wks

Femur

M
Fa

ND
↔

ND
↓

(Pelch et al.
2012)

EE

SpragueDawley

0, 2, 10, or 50 ppb (~0-6
μg/kg bw/d);
In diet

E0-PND70
(Continuous)

10 wks

Femur

M

↔

ND

Vertebra

F
M

↔
↔

ND
ND

(Hotchkiss et al.
2008)

Fa

↓

ND

M
F
M
F

ND
↔
↓
↔

ND
ND
↓
↔

Vertebra

M
F

↓
↔

ND
ND

Femur
Vertebra

M
F
M

↓
ND
↓

↔
ND
↔

Tibia

F
M

ND
↓

ND
ND

Tibia
EB

EB

C57BL/6J

Fischer
CDF

100 μg;
Injection

1 mg/kg/d;
Injection

PND1

16 wks

E19-PND7

12 wks

Femur

(Connelly et al.
2015)

(Fagnant et al.
2014)

F
ND
ND
Abbreviations: BPA: bisphenol A; DES: diethylstilbestrol; E: embryonic day; EB: estradiol benzoate; EE: ethinyl estradiol; F: female; M: male; ND:
Not determined; PND: postnatal day; ↑: increase; ↓: decrease; ↔: no change; aNon-monotonic effect
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Figure 4.1. Femoral bone anatomy and terminology. Major bone types and morphological
parameters assessed by nano-computed tomography (nanoCT) in our exposure study. The shaft
of the long bone (between the gray dotted lines) is primarily composed of cortical bone, while the
distal ends contain more cancellous bone. Cross-sectional bone assessments (inset) in the middiaphyseal region of the femur included: Ct.Ar: cortical area (gray shaded region); Ma.Ar: marrow
area (inner white region); Tt.Ar: total cross-sectional area (gray + inner white regions); Femur Le:
femur length.
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Figure 4.2. Skeletal physiology. Mean stiffness and maximum load for males and females by
generation after adjustments for body mass and age from General Linear Model ANOVAs. Error
bars are standard deviations. The first three bars in each graph represent the males for that
generation while the last three represent the females. Controls are in black, lower dose in dark
grey, and upper dose in light grey. The most pronounced difference is evident for first generation
males because they have reduced stiffness and maximum load to the levels at or below those for
females of the same generation. The adult mouse was the unit of measurement. Moving left to
right through the bars on each graph A and B: F1 generation males (N= 13, 5, and 15) and F1
generation females (N= 8, 4, and 12) C and D: F2 generation males (N= 18, 18, and 21) and F2
generation females (N= 9, 4, and 12). The number of litters represented in each treatment group,
moving left to right through the bars on each graph A and B: F1 generation males (N= 3, 3, and 5)
and F1 generation females (N=2, 1, and 3) C and D: F2 generation males (N=7, 4, 7) and F2
females (N=3, 1, 4).
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Figure 4.3. Proposed pathways of estrogenic EDC-induced skeletal health effects. While
EDCs can act to disrupt epigenetic regulation, and have been shown to elicit effects through
classical and non-classical estrogen receptors, whether these effects are also found in bone
remain to be determined. Moreover, the link between epigenetic regulation and ER/GPER/ERR
signaling in bone are not well-defined. Given the pleiotropic effects of EDCs, direct and indirect
pathways independent of epigenetics and hormone receptors could also affect bone health. Solid
black lines: more established connections in the currently available literature. Gray dashed lines:
Less established connections that remain to be explored. ER: Estrogen receptor; GPER: G
protein coupled receptor; ERR: Estrogen-related receptor.
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CHAPTER 5. FUTURE DIRECTIONS
5.1. BPA and Brain
Future neurobehavioral studies will focus on the neonatal and juvenile stages of
development to address two unresolved questions in our exposure model. First, is the sexspecific behavioral phenotype present prior to puberty? That is, do male-specific behavior
phenotypes depend on gonadal hormone action (or inaction)? Second, are the molecular
changes in adulthood acquired over time, or did the effects arise during direct exposure to BPA
and persist to adulthood? If the molecular changes did not manifest until later in life, sex steroid
hormones could, again, be a critical determinant in the male-specific neurobehavioral outcomes
in adulthood. The sex-specific effects of EDC-induced phenotypes are not only intriguing, but
provide additional insight into their mechanism(s) of action.

5.1.1. Isolation-induced ultrasonic vocalizations are sex-specifically impaired in
neonatal F1 male offspring
Ultrasonic vocalizations (USVs) in neonatal mice function as a signal for retrieval after
physical isolation from the nest (Scattoni et al. 2008). Changes in the number of calls, frequency,
and/or duration of each call may be reflective of a negative affective state (Wöhr et al. 2015). The
directionality of change and its association with a negative affect, however, vary across studies
(Harris et al. 2017; Wöhr et al. 2015). Only one study to date has assessed changes in pup
vocalizations following early life exposure to BPA (Harris et al. 2017). PND8 C57BL/6 offspring
prenatally exposed to 20 µg BPA/day through the diet displayed a trend in increased total number
of calls, although this was not statistically significant (Harris et al. 2017). Further stratification of
calls by frequency and duration identified an increase in the median number of higher frequency
(>65 kHz) calls and an increased proportion of short (0.01 sec) calls (Harris et al. 2017). The
authors speculate that the increased number of high frequency calls may be indicative of
heightened sensitivity to stress, as seen in juvenile (PND28-PND32) mice subject to the same
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exposure paradigm (Harris et al. 2017). No sex differences were observed at PND8 or PND28PND32 (Harris et al. 2017).
In our exposure model, no significant difference in total call number was found in male or
female offspring at either BPA exposure dose at PND5 (data not shown), an age when C57BL/6J
pups are most vocal (Scattoni et al. 2008). Following the stratification of data in a manner
analogous to Harris and colleagues, we did not observe significant differences in the number of
calls based on call frequency or duration (data not shown). However, when data was stratified by
minute of testing, lower and upper dose F1 male offspring exhibited significantly reduced calls
during the first minute of physical separation relative to age-matched controls (Figure 5.1). F1
lower dose females also demonstrated reduced call number during the first minute of testing,
although this was not statistically significant (Figure 5.1). The latency to first call was not
significantly different in either sex or treatment group, although trends towards increased latency
to call were observed in lower and upper dose males as well as lower dose females (Figure 5.1).
The average call duration and frequency were comparable across treatment groups, sex, and
minute of testing (Figure 5.2). Therefore, our findings are the first to show sex-specific affective
behavioral differences at a neonatal stage in BPA-exposed offspring.
Discrepancies between our study and Harris et al. could be due to a variety of factors,
including dose (10 µg or 10 mg/kg bw/d vs. 20 µg/d), exposure window (gestation and lactation
vs. gestation alone), age at assessment (PND5 vs. PND8), and USV testing methodology. To
assess USVs, Harris and colleagues performed two, back-to-back isolation-induced USV
assessments (Harris et al. 2017) while we only conducted a single five-minute test on each
mouse. It is not clear whether Harris et al. observed any significant differences in call features
during the first, five-minute testing period; it is possible that the differences in USV characteristics
did not manifest until the second, five-minute test. The stress associated with prolonged physical
separation from the dam may have exacerbated the effects of gestational BPA exposure in
offspring, as studies have reported hypersensitivity to stress in offspring developmentally
exposed to BPA (Chen et al. 2015). Although the neonatal behavior results across studies thus
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far are inconsistent, both studies suggest early affective behavioral changes are present in
neonatal mice gestationally exposed to BPA. In our exposure model, the detection of behavioral
differences exclusively in males following developmental BPA suggests systemic sex steroids
may not be necessary to elicit sexually dimorphic responses following developmental BPA
exposure.

5.1.2. PND6 hippocampal serotonergic gene expression
Given the observed sex-specific changes in the serotonergic (5-HT) system of adult
animals gestationally and lactationally exposed to BPA, we asked whether disruptions in this
neurotransmitter system surfaced in adulthood or developed at any early age and persisted. The
serotonergic system is one of the earliest neurotransmitter systems to form during mammalian
development and its activity has been reported to be modulated by estrogen (Herlenius and
Lagercrantz 2004; Kajta et al. 2017). Metabolomic studies from our lab also revealed
perturbations in maternal and fetal tryptophan (Susiarjo et al. 2017), the precursor to serotonin,
providing further support for the potential disruption of the serotonergic circuitry by BPA.
In addition to its extensive characterization in behavioral despair (Carr and Lucki 2011;
Nautiyal and Hen 2017), the 5-HT system has also been implicated in altered USV calling (Wöhr
et al. 2015). Pups with deficiencies in the serotonin receptor 1A (Htr1a) or serotonin transporter
(SERT, gene name Slc6a4) exhibit reduced USVs (Richardson-Jones et al. 2011; Wöhr et al.
2015). Heisler and colleagues noted that the affective behavioral impairments in Htr1a KO mice
seemed to impact males more than females (Heisler et al. 1998), although others reported no
apparent sex differences (Toth 2003). Of the 14 known 5-HT receptor subtypes, the 1A receptor
has been best characterized for its role in affective disorders (Carr and Lucki 2011; Nautiyal and
Hen 2017). Polymorphisms in both HTR1A and SLC6A4 have also been associated with
depression risk in humans (Ansorge 2004; Nautiyal and Hen 2017).
Given the aforementioned findings from our labs and others, we queried whether BPA
could disrupt the expression of serotonergic genes in neonatal mice. Using quantitative qRT-
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PCR, we assessed the expression of select serotonergic genes with established roles in affective
behavior (Carr and Lucki 2011) in PND6 male and female hippocampus. We observed significant
decreases in expression of the Slc6a4 and Htr1a in the hippocampus of PND6 upper dose male
offspring (Figure 5.3). Similar reductions in Slc6a4 were observed in F1 female mice (Figure 5.3).
Other 5-HT receptors with suggested roles in anxiety and/or depression (Nautiyal and Hen 2017)
were not significantly affected in BPA-exposed F1 males or females. In sum, BPA exposure
altered the expression of Htr1a in a sex-specific manner, while the mRNA expression of Slc6a4
was similarly reduced in male and female offspring exposed to BPA in neonatal mice. Given the
observed sex-specific behavioral phenotype in adulthood, the sexually dimorphic disruption of
Htr1a and its downstream signaling pathways may be worth further interrogation. On the other
hand, applying unbiased approaches to assess changes in gene expression would provide a
broader scope of the molecular dysregulation associated with BPA exposure and allow for the
prioritization of susceptible pathways. The degree of overlap between the neonatal and adult
hippocampal datasets will also address the persistence of disrupted gene expression.

5.1.3. Sex-specific changes in neonatal hippocampal neurotransmitters
To determine whether disruptions in serotonergic gene expression were associated with
differences in neurotransmitter levels, we performed HPLC in PND6 hippocampus. In addition to
5-HT and its metabolite 5-HIAA, we measured neurotransmitter levels of other biogenic amines
and amino acid neurotransmitters analogous to our adult hippocampal assessments. Unlike the
F1 adult male hippocampus, the F1 PND6 male hippocampus did not show significant differences
in 5-HT or 5HIAA (Figure 5.4). However, significant sex-specific reductions in norepinephrine
(NE) and increases in aspartate were observed in F1 males (Figure 5.4). A dose-dependent
increase in the dopamine metabolite HVA was observed in F1 PND6 females, although this did
not reach statistical significance (Figure 5.4, P = 0.06). Therefore, BPA exposure-associated
effects on hippocampal neurotransmitter abundance were greater in male mice even prior to the
onset of puberty.
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NE levels have been directly correlated with USV call number. The administration of antidepressants or drugs of abuse that increased extracellular NE concurrently increased USVs
(Wöhr et al. 2015). The sex-specific reduction in NE following early life BPA exposure could,
therefore, contribute to the reduced number of calls in male offspring. In humans, depleted or
inactivated NE is associated with depression risk (Schildkraut 1965). Aspartate and glutamate are
agonists of the glutamate receptor subtype, N-methyl-D-aspartate (NMDA) receptor, although the
classification of aspartate as a neurotransmitter has been debated (Ates-Alagoz and Adejare
2013; Herring et al. 2015). Nevertheless, overstimulation of NMDA receptors is associated with
neuropsychiatric disorders, and NMDA receptor antagonists are being utilized in clinical settings
for the treatment of refractory depression (Ates-Alagoz and Adejare 2013). Whether these
transient disruptions in neurotransmitter function are sufficient to alter adult behavior remain to be
determined.

5.1.4. Juvenile behavior testing
Juvenile mice must be of at least weaning age to undergo the same behavior testing
adult animals were subject to (William O’Brien, personal communication). Performing the same
behavior assays in juveniles will allow for a direct comparison of phenotypes across the lifespan.
Of particular interest is the FST phenotype. If the depressive-like phenotype is absent in both
male and female offspring developmentally exposed to BPA, this would suggest circulating
hormones (or lack thereof) are required to initiate the male-specific behavioral despair phenotype
observed in adulthood. If a male-specific phenotype is evident in juveniles, the presence of
circulating sex steroid hormones would not be necessary. Finally, it is possible that both sexes
exhibit a behavioral despair phenotype as juveniles that is then mitigated in females upon
endogenous estrogen exposure. It is known that therapy has anti-depressant effects (EstradaCamarena et al. 2010), suggesting the onset of puberty may alleviate any despair-like behaviors
present in BPA-exposed juvenile female mice. While studies have assessed anxiety in juvenile
mice prenatally exposed to BPA (Harris et al. 2017; Rebuli et al. 2015), no study to date has

85

assessed juvenile behavioral despair. Our preliminary findings in neonatal mice suggest
differential sex susceptibility to BPA exposure in the absence of circulating estrogens and
androgens, supporting a sex-specific genetic or epigenetic basis of vulnerability.

5.2. BPA and Metabolism
The liver is a critical, hormone-sensitive metabolic organ that governs energy metabolism
(Rui 2014). Dysregulation of hepatic fatty acid metabolism associated with obesity can lead to the
accumulation of triglycerides within hepatocytes, resulting in the clinical condition known as
nonalcoholic fatty liver disease (NAFLD) (Alves-Bezerra and Cohen 2017). NAFLD is the hepatic
manifestation of metabolic syndrome and is strongly associated with obesity, insulin resistance
(IR), type 2 diabetes mellitus, and dyslipidemia (Arab et al. 2018; Arslan 2014; Browning and
Horton 2004). NAFLD encompasses a spectrum of liver pathologies ranging from non-alcoholic
hepatic steatosis to move severe aberrations including liver fibrosis and cirrhosis (Liang et al.
2014). A recent epidemiological study reported a positive association between urinary BPA levels
and increased risk of suspected NAFLD in Hispanic adolescents (Verstraete et al. 2018). While
the mechanisms remain unclear, reports in humans and animal models (Shimpi et al. 2017;
Susiarjo et al. 2015) support a role for BPA in the development of NAFLD. In ongoing and future
studies, we will use a multipronged approach to assess the mechanisms underlying BPA
exposure-induced NAFLD.

5.2.1. Liver morphology
Histological scoring systems for NAFLD have been developed for use in clinical as well
as preclinical settings (Liang et al. 2014). In the preclinical model, steatosis and inflammation, two
key features of NAFLD, are scored based on the proportion of total cross-sectional area affected
and number of cell aggregates (i.e. foci) per field of view, respectively (Liang et al. 2014). Hepatic
steatosis, or the net retention of fat resulting from an imbalance between fat uptake and its
oxidation and export (Tolman and Dalpiaz 2007), can be further subcategorized into
macrovesicular steatosis, microvesicular steatosis, and hypertrophy (Liang et al. 2014). The
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strength of this scoring system is the ability to assess individual features as well as derive a
composite score. While many features of NAFLD are recapitulated in rodent models, other
features are rarely present (Liang et al. 2014). Generally, the pathology of NAFLD in mouse
models is less severe than human models, making mouse models appropriate for the early
identification of NAFLD (Liang et al. 2014). Given the sex-specific metabolic defects observed in
our exposure model (Susiarjo et al. 2015), we hypothesize that BPA-exposed adult male mice will
exhibit morphological changes in liver indicative of NAFLD.
Assessments of liver morphology have been an ongoing collaborative effort with Dr.
Benjamin Wilkins at the Children’s Hospital of Philadelphia (CHOP). Preliminary assessments
revealed no significant difference between BPA-exposed F1 or F2 adult mice relative to sexmatched controls. Other, more sensitive, measures of metabolic disruption (e.g. hepatic lipid
accumulation) in the liver are recommended (Benjamin Wilkins, personal communication).

5.2.2. Hepatic lipid accumulation
Obesity and insulin resistance are strongly associated with the deposition of triglyceride
molecules, the major form of fatty acid storage and transport, in the liver and plasma (AlvesBezerra and Cohen 2017; Browning and Horton 2004). Lipid quantification can be performed on
frozen liver sections using Oil Red O staining, which specifically stains triglycerides and
cholesteryl oleate (Ramirez-Zacarias et al. 1992). The quantification of hepatic triglycerides can
also be performed using colorimetric kit-based assays from several manufacturers (Stanbio,
Abcam, Pointe Scientific Inc.).
In our exposure paradigm, we hypothesize that developmental BPA exposure resulting in
male-specific metabolic defects is associated with increased hepatic triglyceride levels. In another
study, livers of F1 CD-1 offspring exposed to BPA from E8-PND35 (25 µg/kg/d via osmotic pump
and drinking water post-weaning) demonstrated increased hepatic lipid content (Shimpi et al.
2017). Interestingly, the effects were more pronounced in female than male offspring (Shimpi et
al. 2017).
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5.2.3. Gene expression and epigenetic regulation
Mechanistic changes associated with BPA-induced metabolic disease are being
uncovered (Li et al. 2014; Ma et al. 2013b; Shimpi et al. 2017). However, work still remains to
determine whether these candidate genes are the primary directors of the disease. Unbiased
approaches such as RNA-sequencing are necessary to determine key genes and pathways
contributing to the exposure-induced phenotypes. Altered DNA methylation at regulatory regions
of candidate lipogenic genes as well as global changes have also been associated with BPA
exposure and diabetes in animal models, providing evidence for an epigenetic link in BPAinduced metabolic disorders (Li et al. 2014; Ma et al. 2013b; Shimpi et al. 2017; Williams et al.
2008).
The National Institute of Environmental Health Sciences (NIEHS) Toxicant Exposures
and Responses by Genomic and Epigenomic Regulators of Transcription (TaRGET) II
Consortium is currently assessing epigenetic and transcriptional changes across the lifespan of
mice exposed to a variety of toxicants (Wang et al. 2018). Goals of the consortium include: (1)
determining the extent to which epigenetic changes persist over time and (2) assessing the
conservation of epigenomic disturbances in target tissues and more accessible surrogate tissues
(e.g. blood, skin) to determine the utility of surrogate tissues as biomarkers of disease risk (Wang
et al. 2018). As a data production center for the consortium, our lab is utilizing our BPA exposure
model to generate initial datasets from liver tissue. Concurrent assessments of genome-wide
chromatin accessibility, DNA methylation, and gene expression via Assay for TransposaseAccessible Chromatin using sequencing (ATAC-seq), Whole Genome Bisulfite Sequencing
(WGBS), and RNA-seq, respectively, are ongoing. Results from these studies will allow for a
greater understanding of the role of epigenetics in exposure-induced gene expression patterning
and disease susceptibility.
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5.3. BPA and Bone
The underlying molecular changes associated with thinner, weaker bones in F1 adult
male mice remain to be elucidated. The combination of histological and molecular approaches
will provide a comprehensive understanding of the cellular changes related to the observed
phenotype. PND21 femurs have also been collected and can be assessed for all endpoints
previously performed and proposed studies in adults.

5.3.1. Bone histology
Standard hematoxylin & eosin (H&E) staining can be performed on decalcified bone.
Osteoblast and osteocyte numbers, as well as marrow adiposity, can be assessed in pre-defined
regions of interest on skeletal cross-sections. In our study, initial assessments will be performed
in the mid-diaphysis of the femur, the same region that was previously examined morphologically
and mechanically. Dynamic histomorphometry, another histological technique, can also be used
to quantify bone cell types while concurrently assessing osteoblast function. Prior to euthanasia,
mice are injected intraperitoneally with fluorophores (ex. calcein) at two different time intervals. In
adult animals, fluorophore injections are administered about eight days prior to euthanasia and
again two days before sacrifice (Kawashima et al. 2009). The fluorophores incorporate into the
newly forming bone, allowing for the assessment of bone formation via fluorescence microscopy.
The degree of labeled surface, known as the mineralizing surface, as well as the distance
between fluorophores, known as the mineral apposition rate (MAR) can be determined. The bone
formation rate can then be calculated as the product of the MAR and the fraction of bone surface
that is labeled (Kawashima et al. 2009). In our exposure model, we hypothesize that BPA
exposure is associated with reduced osteoblast number and/or osteoblast function, which could
be resolved by dynamic histomorphometry. Protocols, logistics, and services have been
discussed with Ms. Shereen Tamsen and are available at the Penn Center for Musculoskeletal
Disease (PCMD) core.
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5.3.2. MSC differentiation capacity
As previously mentioned, mesenchymal stem cells (MSCs) are capable of differentiating
down multiple fates, including adipogenic and osteogenic differentiated cell types (Janesick and
Blumberg 2012). It has been proposed that EDCs that preferentially promote adipocyte
differentiation may do so at the expense of osteoblast differentiation, therefore indirectly
compromising bone health (Janesick and Blumberg 2012). Because we have observed
concurrent increases in body fat as well as decreased bone formation (Susiarjo et al. 2015; Xin et
al. 2018), BPA may be acting on MSCs to skew differentiation towards an adipogenic cell fate.
Differentiation capacity can be assessed in MSCs derived from adipose (Kirchner et al. 2010) or
bone marrow (Chamorro-García et al. 2013). Preliminary assessments can also be performed in
mouse embryonic fibroblasts (MEFs) (Girish Ramaswamy, personal communication).
Differentiation media to promote adipocyte and osteoblastic fates have been previously described
(Kirchner et al. 2010). Cells can be collected at multiple time points to assess the expression of
established early and late adipocyte (ex. Pparg, Fabp4, Pref-1, Leptin, Adipoq) as well as
osteoblast (ex. Runx2, Alp, Opn, Osc) markers (Chamorro-García et al. 2013; Kirchner et al.
2010). In cells prompted towards an osteogenic fate, calcium accumulation can be determined by
Alizarin Red S staining (Kirchner et al. 2010). In cells prompted towards an adipogenic fate, Oil
Red O staining can be performed to assess lipid vacuoles. In all staining processes, not only can
the absolute production be assessed but also the rate of calcium or lipid production in lineageinduced MSCs of BPA-exposed offspring.

5.3.3. Skeletal gene expression
Molecular assessments in bone tissue can also be pursued to assess skeletal
dysregulation associated with EDC exposure. However, obtaining high quality nucleic acid,
especially RNA, has historically been challenging given low cell counts embedded in highly
mineralized tissue (Carter et al. 2012). Previous methods for extracting RNA from bone included
mechanical disruption using a hammer or mortar and pestle to grind the tissue into a powder
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(Carter et al. 2012). Newer methods include homogenizing with Bullet Blender (Next Advance)
centrifuge technology or a Polytron tissue homogenizer while maintaining samples at nearfreezing temperatures (Carter et al. 2012). The solubilized bone extract is then isolated and RNA
purification can proceed using standard extraction methods (Carter et al. 2012). Using these
newer techniques, RNA integrity numbers averaged around 8.28 compared to 5.65 using
previously described methods (Carter et al. 2012).

5.3.4. Serum biomarker assessments
Finally, serum assessments of bone turnover can be performed by ELISA (Dr. Robert
Tower, personal communication). Commonly used circulating markers include proteins
associated with bone formation (e.g. P1NP, ALP, OCN) as well as resorption (TRAP5B, CTX)
(Fisher et al. 2018; Greeviroj et al. 2018; Yao et al. 2017). We hypothesize that BPA exposure is
primarily associated with reduced bone formation. Although the transverse growth of the femur
was impaired in F1 BPA-exposed males, the cortical area was properly adapted to the narrower
structure, suggesting bone resorption processes occurring on the endocortical surface may be
intact.

5.4. Conclusion
Our understanding of how EDCs act, and whether their effects can be transmitted across
multiple generations, continues to grow. Although causal relationships between EDC exposure
and disease endpoints have not been fully established, there is strong evidence to demonstrate
that the ubiquitous presence of EDCs in the environment should not go unnoticed. Because EDC
exposures elicit a myriad of phenotypes, it is unlikely that they act through any single mechanism.
In fact, the hallmark non-monotonic dose responses of EDCs may be due to distinct mechanisms
of action at each dose, further complicating the identification of causal factors driving the
observed physiological changes.
While single compound exposure models provide a critical starting point to understand
the mechanisms of EDC action, newer models are now being employed to more accurately depict
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human exposures to EDCs. Because humans are rarely, if ever, exposed to EDCs in isolation,
studies assessing multi-compound exposure effects are critical. It is not well-understood how the
presence of other chemicals may influence the activity of each EDC alone and will require further
investigation. Additionally, an increasingly common experimental model utilized by researchers in
the EDC exposure field is the application of a postnatal challenge to assess altered
responsiveness to adverse stimuli. Analogous to Knudson’s two-hit, or multiple-hit, hypothesis of
carcinogenesis (Knudson 1971), the premise of this paradigm is that the molecular changes
induced by developmental EDC exposure are not sufficient on their own to elicit gross
physiological differences across the lifespan. Rather, the underlying molecular changes may be
primed for an exacerbated response to a second event. The second event, or challenge, could
vary depending on the physiological endpoint of interest. For example, in the context metabolic
dysfunction, a high-fat diet could be employed to determine whether developmental EDC
exposure heightens diet-induced obesity and insulin resistance (Strakovsky et al. 2015; Wang
and Liao 2012). Finally, given our inevitable exposure to BPA and other chemicals, the
identification of dysregulated molecular pathways may guide intervention strategies to reduce
exposure-associated risks are warranted. For example, nutrient supplementation such as folate
and vitamin B6 have been shown to counteract BPA exposure-induced phenotypes (Dolinoy et al.
2007; Susiarjo et al. 2017).
Studies from our lab and others have demonstrated fetal and neonatal susceptibility to a
multitude of EDC exposure-associated effects. However, whether epigenetic dysregulation is
responsible for the EDC-induced changes across generations of offspring still requires further
study. The concept of multi- and transgenerational epigenetic inheritance greatly alters the public
health perception and risk of EDCs – not only does the health of the directly exposed generations
need be considered, but the transmission of altered health outcomes and disease susceptibility to
future generations must also be taken into account. While the safety of BPA remains a greatly
debated topic, anticipatory measures should be taken in the face of events that that may pose a
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risk to human health (Syberg and Hansen 2016). Applying the precautionary principle to EDCs
may help to reduce the incidence of various diseases with currently unknown etiology.

5.5. Contributions
This chapter includes direct quotes from Xin et al. published in 2015 in Seminars in Cell &
Developmental Biology. For the unpublished/preliminary brain project data, the Neurobehavior
Testing Core (NTC, Dr. Tim O’ Brien and Brianna Ciesielski) provided equipment for testing and
data analysis. Dr. Elizabeth Krizman (CHOP, Robinson Lab) performed the neurotransmitter
assessments. For the metabolic endpoints, Dr. Benjamin Wilkins (CHOP) helped score liver
morphology. Planning of future skeletal endpoints and experiments would not have been possible
without the input from Dr. Eileen Shore, Dr. Girish Ramaswamy (post-doc, Shore laboratory), Dr.
Ling Qin, Dr. Lachlan Smith, Dr. Robert Tower (post-doc, Qin laboratory), and Ms. Shereen
Tamsen of the Penn Center for Musculoskeletal Disorder (PCMD).
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Figure 5.1. Postnatal day (PND) 5 isolation-induced ultrasonic vocalizations (USVs). Two
pups per sex per litter were selected for each test, when possible. The pup was the unit of
measurement. Average call number was significantly reduced in BPA-exposed lower and upper
dose male mice, while females were not significantly affected during the first minute of isolation.
No significant differences in call number were apparent during the remaining four minutes of
testing. Graphs display mean ± SEM. Linear mixed effects with multiple testing correction. * p <
0.05
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Figure 5.2. Average USV call frequency and duration. Average USV call frequency and call
duration are not affected by BPA exposure in PND5 male or female offspring. No significant
differences in call frequency or duration were observed when analysis was stratified by minute
(data not shown). Graphs display mean ± SEM. The pup was the unit of measure. Linear mixed
effects with multiple testing correction. * p < 0.05
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Figure 5.3. mRNA expression of serotonergic genes in PND6 hippocampus. Serotonin
transporter (Slc6a4) and serotonin receptor subtypes implicated in human affective disorders
were assessed by qRT-PCR. Significant differences in Slc6a4 and Htr1a were observed. Graphs
display mean ± SEM. The pup was the unit of measure. Sample sizes and litter numbers (in
parentheses) indicated below each graph. Linear mixed effects with multiple testing correction.
* p < 0.05
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Figure 5.4. Neurotransmitter assessments in PND6 male and female hippocampus. Sexspecific differences in neurotransmitter abundance are evident prior to the onset of puberty.
Graphs display mean ± SEM. The pup was the unit of measure. Sample sizes and litter numbers
(in parentheses) indicated below each graph. Linear mixed effects with multiple testing correction.
** p < 0.01. 5HT: serotonin, 5HIAA: 5-hydroxyindoleacetic acid; NE: norepinephrine; HVA:
homovanillic acid; Gln: glutamine; Glu glutamate; GABA: gamma-aminobutyric acid; Asp:
Aspartate
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CHAPTER 6. MATERIALS & METHODS
Direct quotes were taken from Xin et al. published in 2018 in Environmental Epigenetics and an
unpublished paper by Xin et al. currently under review at Hormones and Behavior.

6.1. Animals
All animal studies were approved by the Institutional Animal Care and Use Committee at
the University of Pennsylvania. The animals used in this study were treated humanely and with
regard for alleviation of suffering. Mice were maintained on a 12:12-h light/dark cycle, with lights
on at 07:00 (based on a 24-hour time system) and temperature maintained at 25oC ± 2oC.
Drinking water was provided in polypropylene bottles. To verify robustness of phenotypes,
animals and/or tissues from multiple cohorts and two different animal facilities were used when
possible.

6.2. Bisphenol A (BPA) diet formulation
Bisphenol A (BPA; CAS 80-05-7; Sigma ≥99% purity)-supplemented feed was purchased
from Envigo (Madison, WI). The control diet was a modified, low phytoestrogen, AIN 93G diet (TD
95092 with 7% corn oil substituted for 7% soybean oil to minimize exposure to other estrogen-like
compounds that could confound BPA-related effects), and BPA diets included 50 μg BPA/kg diet
(lower dose BPA; TD 110337) and 50 mg BPA/kg diet (upper dose BPA; TD 06156)
supplemented into the control diet to approximate exposures of 10 μg and 10 mg BPA per kg
bw/d (Dolinoy et al. 2007).

6.3. BPA exposure
Six-week-old virgin C57BL/6J female mice (designated F0 generation, purchased from
The Jackson Laboratory) were randomly assigned to control or BPA-containing diets beginning
two weeks prior to mating. Females were mated to unexposed C57BL/6J male mice during each
cohort of exposure. Upon detection of a vaginal plug, females were separated from males. No
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females were mated for more than two weeks. Exposures continued throughout mating,
gestation, and lactation. We previously reported no differences in maternal food consumption
between control and BPA-exposed dams (Susiarjo et al. 2013). The start of this exposure window
coincides with the acquisition of epigenetic marks in late oocyte maturation that may be
susceptible to environmentally-induced disruption and subsequently influence offspring health
(Smallwood et al. 2011). Postnatal exposure to BPA was included in our study because the
differentiation and development of the early postnatal rodent brain corresponds to the second and
third trimesters of human fetal brain development (Palanza et al. 2016; Williams et al. 2013).
The levels of exposure fall below established reference doses for BPA that are
considered safe for humans: the tolerable daily intake (TDI; 50 μg/kg bw/d), defined by the
European Food Safety Authority (Bolt and Stewart 2011), and the lowest observed adverse effect
level (LOAEL; 50 mg/kg bw/d), defined by the United States Environmental Protection Agency
(Integrated Risk Information System (IRIS) 1988). Moreover, we previously assessed circulating
levels of BPA in F0 maternal serum (Susiarjo et al. 2013) and found levels to be comparable to
human exposures (Schönfelder et al. 2002; Vandenberg et al. 2007).
All F1 generation offspring were weaned on postnatal day (PND) 21 and maintained on
control diets throughout the remainder of the studies. No differences in litter size or sex ratio were
observed, and no culling of litters was performed. To generate F2 offspring, a subset of six-weekold F1 females (one to two females per litter) were randomly selected to be mated to unexposed
males. Animals used for adult physiological testing, aged 14-20 weeks, were randomly selected.
No F1 or F2 offspring were singly housed.

6.4 BPA and brain
6.4.1. Adult behavior testing
F1 adult behavior testing was conducted on male and female mice aged 16-20 weeks.
Tests were conducted in order of least to most distressing and offspring were allowed at least one
day of rest between tests. Equipment was wiped with 70% ethanol and allowed to dry between
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tests. High definition digital recordings of all behavior procedures were collected for offline
analysis. All behavior testing was completed by two trained observers blind to group designation,
and analyses were completed by one trained observer to ensure consistency across cohorts of
behavior tests. We controlled for time-of-day effects (Roedel et al. 2006) by beginning and ending
assessments at the same time across testing days. Adult behavior testing was initially conducted
in males, and behaviors altered by early life BPA exposure were then assessed in females to
address sex-specificity. For early-life behavior testing (i.e. mother-offspring behavior), cages were
checked for parturition daily at 08:00. The day of birth was considered postnatal day one (PND1).

Hole Poke (HP)
Exploration of a 14 x 14 inch arena with a lattice of 16 holes in the floor was conducted in
the light between 07:00 and 10:00 on adult F1 male and female offspring as well as F2 adult
males. Exploratory and general locomotor activity was assessed by infrared light beam emitters
and detectors within the holes and in a scaffold around the arena. A computer interface system
(PAS-Open Field, San Diego Instruments) recorded hole pokes, horizontal and vertical beam
breaks in a ten-minute trail.

Elevated Zero Maze (EZM)
The EZM was used to assess anxiety-related behavior in F1 adult male mice. This test
was conducted in the light between 07:00 and 10:00. Mice were placed on an annular track
elevated ~80 cm from the floor and divided into quadrants: 2 opposing quadrants were bordered
on either side by 10cm high walls (considered the closed arms of the track) while the other 2
quadrants remained open. Individual mice were placed in a closed arm of the maze and recorded
for a five-minute trial. Increased time spent in the open arms of the maze is interpreted as a
reduction in anxiety-like behavior (Braun et al. 2011). Image analysis was performed on open
source MatLab-based software (Patel et al. 2014). Time in the open and closed segments of the
maze and distance traveled during the trail were determined.
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Social Choice (SC)
The SC procedure is used to identify impaired social interactions in adult F1 male mice.
SC was conducted later in the day, between 10:00 and 14:00, and in low light (~10 lux), to
enhance activity and exploration towards the inanimate and social cues during the assessment
(Sankoorikal et al. 2006). A three chamber social choice arena was used as described elsewhere
(Sankoorikal et al. 2006). Briefly, the arena is configured to contain ventilated plastic cylinders on
either side of the arena. The cylinders are used to hold a non-social object (rock) and a social
object (same sex gonadectomized A/J mouse) in opposite sides of the arena. After a ten-minute
habitation to the arena with empty cylinders, a non-social and social cue were loaded in their
respective cylinders for a ten-minute social preference phase. In a third phase of the procedure,
the cylinders are removed and the mice are allowed to directly interact with the social cue mouse
and the non-social cue for five minutes. The interaction phase time is graded for aggression. An
open source program developed by David Meany
(http://www.seas.upenn.edu/~molneuro/autotyping.html) was used to analyze the social choice
procedure recordings: this analysis compares the amount of time that the tested mouse interacts
with the target mouse during the second phase of testing.

Forced Swim Test (FST)
Porsolt’s FST was performed in the light between 07:00 and 10:00. Adult male (F1 and
F2 generations) and female (F1 only) mice were tested in 46 x 22 cm diameter glass cylinders
filled to a depth of about 20 cm with water (25 ± 1°C) from which there was no escape. A single
six-minute trial was performed. The first two minutes of the test were ungraded time to allow for
acclimatization to the cylinder. During the remaining four minutes of the trial, total time spent
immobile was recorded. Increased time spent immobile is sensitive to antidepressants and is
related to depressive-type behavior (Cryan and Mombereau 2004; Porsolt et al. 1977). Following
behavior testing, estrus stage (mete/diestrus, proestrus, estrus), was determined in F1 females
by vaginal smears (McLean et al. 2012).
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Rescue Experiment
The selective serotonin reuptake inhibitor fluoxetine hydrochloride (F132 Sigma) was
resuspended in 0.9% saline at a concentration of 2 mg/mL. Beginning at 07:30, adult male mice
(16 weeks) were administered saline or fluoxetine (20 mg/kg bw) intraperitoneally thirty minutes
prior to FST. The dose of fluoxetine (20 mg/kg bw) was selected based on previous studies using
C57BL/6 mice of comparable ages (Bahi et al. 2014; Tang et al. 2014).

Nest quality
Maternal care was assessed in F0 dams on the day of parturition. Assessments of nest
quality were conducted at 08:00 on PND1. One compressed cotton square was provided to each
dam for nest building. The scoring system used has been described elsewhere (Hess et al.
2008). In brief, nests are scored based on the shape and height of walls built up around the pups.
Scores range from 0 (undisturbed nesting material) to 5 (complete dome).

Pup retrieval
Pup retrieval was conducted in the light between 08:30 and 10:30 on PND1. Two pups
were gently removed from the nest and placed in each of the corners furthest from the nest.
Recordings lasted for 10 minutes. Latency to carry the first pup, retrieve the first pup to the nest,
and total time to return both pups to the nest were assessed as previously described (Myers et al.
1989). Additionally, the relative amount of time the F0 dam spent in the nest, irrespective of the
type of behavior exhibited in the nest, and the time spent actively adjusting nest materials were
noted (Myers et al. 1989; Palanza et al. 2002).

6.4.2. Tissue harvest and RNA isolation
Following behavior testing, mice were allowed to recover for at least one week prior to
euthanasia. Adult mice were euthanized by cervical dislocation. Animals were sacrificed in
random order. Whole blood was collected immediately after euthanasia and allowed to clot for 30
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minutes at room temperature. Samples were subsequently centrifuged at 10,000 rpm at 4°C for
10 min. The supernatant, designated serum, was quickly removed and stored at -80oC until
further analysis. Whole hippocampal tissue from each hemisphere was individually dissected and
flash frozen in liquid nitrogen to allow for multiple downstream molecular assessments per
animal. To ensure consistency in whole hippocampal tissue isolations, the same researcher
dissected each mouse.
Total RNA was extracted from whole hippocampus using the RNeasy Mini Kit (QIAGEN)
following the manufacturer’s instructions. RNA concentrations were determined using the Nano
Drop spectrophotometer, and 350 ng of RNA was run on an agarose gel to assess RNA quality.

6.4.3. RNA-sequencing (RNA-seq)
Four control and four upper dose BPA adult (20 week) male hippocampal samples from
behavior-tested mice were used for the RNA-Seq study. 5μg of total RNA was used as input for
poly(A)+ selection using Dynabeads mRNA DIRECT purification kit (Ambion). Barcoded libraries
were made using ScriptSeq v2 RNA-Seq Library Preparation Kit (Illumina) and ScriptSeq Index
PCR Primers (Illumina). Library quality was assessed on an Agilent 2100 Bioanalyzer system and
quantified using the Kapa quantification kit (Kapa Biosystems). Sequencing was performed on a
NextSeq 500 platform (Illumina).
RNA-seq reads were trimmed for quality using Trimmomatic (version 0.32) (Bolger et al.
2014). Leading and trailing low quality (below quality 3) and N base calls were trimmed, and
reads were scanned using a 4-bp sliding window and trimmed when the average quality per base
dropped below 15. Reads with at least 30 bp in length following this quality control process were
retained and used for subsequent analyses. The resulting reads were then aligned to mm10
reference genome assembly using STAR (version 2.3.0e) (Dobin et al. 2013), allowing read pairs
to align no farther than 2000bp apart and keeping only unique, concordantly aligned read pairs for
genome-wide transcript counting. FeatureCounts (version 1.5.0) (Liao et al. 2014) was used to
generate a matrix of mapped fragments per RefSeq annotated gene. Numbers for total
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sequenced, aligned and counted reads for each sample are listed in Supplemental Table 1.
Analysis for differential gene expression was performed using DESeq2 (Love et al. 2014) with the
cutoff of FDR < 0.05 (Supplemental Dataset 1). Using these differentially expressed genes
(DEGs) as input, we performed Core Analysis provided by the Ingenuity Pathway Analysis (IPA)
software. This analysis interpreted our dataset in the form of canonical pathways and upstream
regulators that were overrepresented in the DEG list. All default parameters were used.
Clustering and heatmap of differentially expressed genes were generated using heatmaply R
package. The raw sequencing data reported in this work have been deposited in the NCBI Gene
Expression Omnibus under accession number GSE102849.

6.4.4. Quantitative real-time PCR (qRT-PCR)
RNA was treated with RQ1 RNase-Free DNase (Promega) prior to cDNA conversion
using Superscript III reverse transcriptase (Invitrogen) and random hexamers (Roche). qRT-PCR
was run on a 7900HT Fast Real Time PCR system (Applied Biosystems). Samples were run in
triplicate using the following recipe: 5 µl of Power SYBR green PCR Master Mix (Applied
Biosystems), 0.2 μl of forward primer (10 μM), 0.2 μl of reverse primer (10 μM), and 4.6 μl of
cDNA (5 ng). Whole hippocampal gene expression from behavior-tested and non-tested animals
was normalized to Tbp and Hprt, and expression relative to control was calculated using the
comparative Ct method. Primer sequences for the genes of interest can be found in Table 6.1.

6.4.5. High performance liquid chromatography (HPLC) analysis of biogenic
amines and amino acids
The F1 male and female adult hippocampal tissues from behavior-tested and non-tested
animals were processed and analyzed by a researcher blinded to treatment. The hippocampus
was sonicated for 10 seconds in homogenization buffer (22 mM sodium acetate, 74.8 mM glacial
acetic acid, 0.05mM EDTA pH 4.95) containing 250nM 3,4-dihydroxybenzylamine (internal
standard for biogenic amines) and 1mM L-alpha-aminoadipate (internal standard for amino acids)
then centrifuged at 14,000 rpm at 0°C for 30 min. An aliquot of the supernatant (30 µl) was
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diluted with 5ul of 0.3mg/ml ascorbate oxidase and 20 µl of this dilution was used for biogenic
amine analysis as described previously (Stein et al. 2006). A second aliquot (10 µl) was diluted
1:1 with 0.8 N perchloric acid (10 µl) and analyzed for amino acids as described previously
(Kilpatrick et al. 2010). In three samples, DOPAC was not well resolved, in three samples NE was
not well resolved, and in one sample DA was not resolved; these values were excluded from the
analysis prior to unblinding.

6.4.6. Liquid chromatography-high resolution mass spectrometry (LC-HRMS)
Testosterone, dehydroepiandrosterone (DHEA) and estrone assays were performed on
50 µL serum from behavior-tested and non-tested animals after digestion with βglucuronidase/arylsulfatase from Helix pomatia as previously described using LC-HRMS with
13C

3-testosterone

as an internal standard (Frey et al. 2016). The limit of quantification (LOQ) was

20 pg/mL serum for testosterone and DHEA and 25 pg/mL for estrone. In tissue, the LOQ for
testosterone, DHEA, and estrone were 20 pg, 15 pg, and 5 pg per gram of tissue, respectively.
Imputation of data values below the LOQ were performed as previously described (Hornung and
Reed 1990; Succop et al. 2004).

6.4.7. Statistical analysis
Given the intralitter variability commonly seen in our exposure model (Susiarjo et al.
2013), we randomly selected at least two animals/sex/litter, when possible, for physiological and
molecular studies. The adult offspring was the experimental unit. All values are reported as mean
± SEM. To account for the presence of multiple animals per litter, we used linear mixed effects
modeling (Stata 14.2). P-values were adjusted for multiple comparisons. p <0.05 was considered
statistically significant.
Because the sex steroid data did not meet the assumption of normality, a non-parametric
test was used. A Kruskal-Wallis H test was used to determine if sex steroid levels were different
across the three treatment groups followed by the Dunn-Bonferroni post hoc method. Again, p
<0.05 was considered statistically significant.
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Effect size estimates were calculated using Cohen’s d for pair-wise comparisons and eta
squared (η2) for Kruskal-Wallis. Cohen’s d was calculated using an effect size calculator found at
http://www.campbellcollaboration.org/escalc/html/EffectSizeCalculator-SMD1.php (Wellman et al.
2018). The η2 estimate was calculated manually as previously described (Tomczak and Tomczak
2014).

6.5. BPA and metabolism
6.5.1. Adult metabolic assessments
Glucose tolerance test (GTT)
GTTs were conducted between PND98-PND117 for adult F1 and F2 offspring and
between E16.5-E17.5 for gestational glucose tolerance studies. Following an overnight (~16
hour) fast, mice were injected intraperitoneally with a 2 g/kg bw bolus of glucose. Blood-glucose
levels were recorded using a handheld glucometer at 0, 15, 30, 60, and 120 minutes following
glucose administration. GTTs were conducted by a trained, blinded observer.
Glucose area under the curve (AUC) was calculated using GraphPad Prism. The
baseline values were adjusted for each individual mouse based on the lowest recorded bloodglucose level. Average AUCs by sex and treatment group were compared.

Dual Energy X-ray absorptiometry (DEXA)
DEXA scans were performed in collaboration with the Mouse Phenotyping, Physiology,
and Metabolism Core on the first floor of Smilow Center for Translational Research (former
director: Dr. Rexford Ahima, currently Dr. Joseph Baur) with the help of Research Specialists Dr.
Xiaoyan Yin and Mr. Charles Cudjo Addo-Yobo.
Adult mice were anesthetized using isoflurane throughout the duration of the scan. DEXA
scans were performed using a GE Luna PIXImus x-ray densitometer. Whole body scans were
conducted, and acquired measurements included body fat, lean mass, bone mineral content, and
bone mineral density. Each scan lasted about 5 minutes.
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Islet perifusion studies
Perifusion studies were performed in collaboration with Dr. Changhong Li at the
Children’s Hospital of Philadelphia (CHOP) based on previously published methods (Li et al.
2003). Fasting blood insulin levels were assessed by ELISA (ALPACO). Pancreatic islets were
isolated by collagenase digestion followed by culture for two days in RPMI 1640 medium (SigmaAldrich). To assess glucose-stimulated insulin secretion, islets were perifused in a Krebs-Ringer
bicarbonate buffer with 0.25% bovine serum albumin at a flow rate of 1 mL/min. Glucose ramps
were administered at a rate of 0.5 mM/min. 30 mM of KCl was used at the end of the experiment
to determine maximum insulin release. Samples were collected at every minute of the study, and
insulin was measured by homogeneous time-resolved fluorescence technology (Cisbio kit).

6.5.2. Fetal molecular assessments
Allelic expression studies
Allele-specific expression studies were performed in E9.5-E10.5 F2 hybrid whole
embryos. Imprinted genes of interest included Igf2, H19, Snrpn, Kcnq1ot1, and Peg3. Allelic
expression was determined via RT-PCR followed by restriction fragment length polymorphism
analysis. For Snrpn, we will use the Light Cycler real-time PCR system (Roche), which consists of
a melting curve assay using probes specific for the ICR SNPs. Because each single nucleotide
polymorphism (SNP) has a characteristic melting temperature, quantification of allelic expression
can be completed by assessing the area under the curve in a derivative plot. Samples displaying
10% or more of the total expression derived from the normally repressed allele are considered to
exhibit loss of imprinting (LOI) or biallelic expression. The proportion of samples displaying LOI is
then calculated for each exposure group, and the chi-squared statistical test is used to assess
statistical significance.

Bisulfite conversion and pyrosequencing
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Pyrosequencing was performed to assess DNA methylation status at 4 CpG sites in Igf2
DMR1. Genomic DNA (1 µg) was first bisulfite treated using the EpiTect Bisulfite kit (Qiagen),
following the manufacturer’s protocol. 50 ng of bisulfite-treated DNA was used per 25 µL PCR
reaction using the PyroMark PCR kit (Qiagen), following the protocol supplied by the
manufacturer. Pyro PCR conditions were: 95°C for 15 minutes followed by 45 cycles of 95°C for
15 seconds, 58°C for 30 seconds, and 72°C for 15 seconds. 10 µL of the biotinylated PCR
product was then used for pyrosequencing using the PyroMark Q96MD (Qiagen) system and the
PyroMark Gold 96 reagents kit (Qiagen). DNA methylation analysis was performed using Pyro QCpG software (Qiagen).

6.6. BPA and bone
6.6.1. Nano-computed tomography (nanoCT)
Same-sex siblings were used within a treatment group, and litter numbers are indicated
in the legend of Figure 4.2. The decision to use same-sex siblings was based on our previously
published study (Susiarjo et al. 2013) demonstrating a high degree of intra-litter variability,
suggesting the observed changes determined in one animal are not necessarily representative of
other animals in the litter. Clustering analysis demonstrated that animals within a litter did not
tend to cluster with one another more than other non-sibling animals within a treatment group
(data not shown). Therefore, the individual adult animal was used as the unit of measurement.
Additional analysis was performed using the dam as the unit of measurement (i.e. averaging all
values of offspring from one litter into a single data point). We confirmed the differences in
skeletal parameters across treatment groups exhibited the same trends, and the average value
within a treatment group was not due to one deviant litter biasing the group average (data not
shown).
Treatment group allocation and sex of each specimen remained blinded until
quantification was complete. Left femurs of adult male and female F1 and F2 (13-22 weeks) were
excised, cleaned of soft tissue, and stored at -40⁰C in phosphate buffered saline (PBS). Body
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weights (BWs) were recorded prior to euthanasia. Since this was an ad-hoc study, a more limited
age specification was not achievable. However, the 13-22 week time point represents an adult
age when bone mass and external size show very little age-related change (Price et al. 2005).
Cross-sectional morphology was quantified as previously described, using a threedimensional high resolution nano-computed tomography imaging system (nanoCT, nanotom-s;
phoenix|x-ray, GE Sensing & Inspection Technologies, GmbH; Wunstorf, Germany) described
(Smith et al. 2013a, 2014). NanoCT imaging was performed at 8 µm voxel size using image
acquisition parameters (diamond-tungsten target, 1000 milliseconds exposure, 3 averages, 1
skip, 720 images, 90 kV and 375 µA tube settings, and a 0.3 mm aluminum filter) and specimen
set-up similar to that reported previously (Smith et al. 2014). Volumes were reconstructed using
datos|x reconstruction 2.1 (phoenix|x-ray, GE Sensing & Inspection Technologies, GmbH;
Wunstorf, Germany) and grey values were converted to Hounsfield units on a scan-by-scan basis
using a custom-made calibration phantom and a custom software interface. A 2.5 mm section of
the mid-diaphysis of each femur corresponding to the location of failure in the bending tests was
thresholded on a per sample basis using the method of Otsu (Otsu 1979) and then used to
quantify cortical area (Ct.Ar), marrow area (Ma.Ar), total area (Tt.Ar), and tissue mineral density
(TMD) using MicroView Advanced Bone Analysis Application (v2.2, GE Healthcare Pre-Clinical
Imaging, London, ON, Canada). Digital micrometers (0.05 mm resolution) were used to measure
femoral length (Femur Le) that was then used to calculate robustness (Tt.Ar/Femur Le).

6.6.2. Four-point bending
After imaging, left femurs were loaded to failure in 4-point bending at 0.05 mm/sec using
a servo-hydraulic material testing system (MTS 858 MiniBionix, Eden Prairie, MN) to quantify
biomechanical properties as previously described (Jepsen et al. 1996; Schlecht and Jepsen
2013; Smith et al. 2013a). Each femur was loaded to failure with the anterior surface subjected to
tensile loads on a test fixture having 6.35 mm lower span length and 2.2 mm upper span length.
Samples were kept moist with 1X phosphate buffered saline solution during testing that occurred
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at room temperature. Load-deflection curves were used to calculate stiffness (S), maximum load
(ML), post-yield deflection (PYD), and work-to-fracture (work) as reported previously (Jepsen et
al. 1996, 2001). Whole bone strength is used synonymously with maximum load. Treatment
group allocation and sex of each specimen remained blinded until all quantification was complete.

6.6.3. Statistical analysis
Prior to unblinding and statistical analyses, all traits were adjusted for previously
established covariates known to be associated with skeletal morphology and whole bone
mechanical properties (Schlecht and Jepsen 2013; Smith et al. 2013b). By using adjusted traits
for the statistical analysis, we were able to minimize the contribution of the covariates in our
determination of exposure-associated effects on skeletal outcomes. The adjustment was
performed by GLM ANOVAs (i.e., a generalized version of a multiple regression model). The
exact covariates used in each model varied depending on the trait being modeled. For BW and
femur length: age was the only covariate included in the model. For total area (Tt.Ar), marrow
area (Ma.Ar), robustnesss, and the mechanical traits: age and BW were covariates in the model.
Finally, for cortical area (Ct.Ar) and tissue mineral density (TMD): age, BW, and robustness were
included as covariates, as our previous work reported positive and negative associations of Ct.Ar
and TMD with robustness, respectively (Schlecht and Jepsen 2013). Adjusting Ct.Ar and TMD for
BW, age, and robustness allowed us to determine whether BPA exposure affected the ability of
the system to accommodate for variations in external bone size.
Following adjustments, samples were unblinded for treatment group and sex, and
statistical analysis was performed with a single factor (i.e., treatment) general linear model (GLM)
ANOVA (Minitab 16.2.3; Minitab Inc, State College, PA, USA) for each sex and generation
combination. Adjusted traits by treatment group were compared back to their sex-matched
controls individually using Student’s t-test. A standard significant threshold of p < 0.05 was used
in all cases.
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6.7. Future directions
6.7.1. BPA and brain
Isolation-induced ultrasonic vocalizations (USVs)
USV testing was conducted between 08:00 and 10:30 on PND5. Detailed methods have
been published elsewhere (Scattoni et al. 2008). Two males and two females per litter were
tested when possible. Animals were individually placed into a bedded glass container within a
sound-proof foam container with a microphone. USVs were recorded for 5 minutes using Avisoft
Recorder software. Call number, frequency, and duration were assessed using Avisoft software.
Samples were blinded until all analyses were complete. USVs were performed in two
independent cohorts of offspring.

6.7.2. BPA and metabolism
Liver histology
Liver histology was performed on formalin-fixed, paraffin-embedded, adult liver tissue.
Hematoxylin and eosin (H&E)-stained slides were delivered to Dr. Benjamin Wilkins (CHOP), who
scored samples based on previously published methods (Liang et al. 2014). Dr. Wilkins remained
blinded to treatment group until all analyses were complete.
The preclinical NAFLD grading system described by Liang and colleagues segments
scoring into two major components: steatosis and inflammation (Liang et al. 2014). Steatosis is
further subdivided into micro- and macrovesicular steatosis as well as hypertrophy. Hypertrophy
is defined as an abnormal enlargement of the cell greater than 1.5 times the normal diameter of a
hepatocyte. The severity of steatosis was determined based on the percentage of total area
affected. Inflammation is scored based on the number of inflammatory cell aggregates or foci per
field of view. Possible assigned scores range from a scale of 0-3 for each endpoint, with larger
numbers indicative of increased severity.
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Supplemental Table 6.1 qRT-PCR primer sequences for brain RNA-seq validation.
Gene

Forward primer (5’-3’)

Reverse primer (5’-3’)

name

Size
(bp)

Hprt

GGCCATCTGCCTAGTAAAGCT

GTCGGCCTATAGGCTCATAGT

121

Tbp

CAGCAATCAACATCTCAGCAA

GGGGTCATAGGAGTCATTGGT

137

Th

GCCGTCTCAGAGCAGGATAC

CATCCTCGATGAGACTCTGCC

85

ACCACCCTGGACATCAACC

CTGACAAGGCCTGGAAGTTG

112

Grik5
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